# Coty Inc.: Form 10-Q for the period ended Mar 31, 2020

- Company: [Coty Inc.](/companies/coty.md) (CIK 1024305)
- Form: 10-Q
- Filed: 2020-05-11
- Accepted by EDGAR: May 11, 2020, 17:07 ET
- Period: 2020-03-31
- Accession: 0001024305-20-000049
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1024305/000102430520000049/coty-20200331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1024305/000102430520000049/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2020-01-01 to 2020-03-31 | $1.53bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months, 2019-07-01 to 2020-03-31 | $5.82bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2020-01-01 to 2020-03-31 | $617.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months, 2019-07-01 to 2020-03-31 | $2.21bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2020-01-01 to 2020-03-31 | $910.9m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2019-07-01 to 2020-03-31 | $3.60bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2020-01-01 to 2020-03-31 | $999.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2019-07-01 to 2020-03-31 | $3.27bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2020-01-01 to 2020-03-31 | −$258.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2019-07-01 to 2020-03-31 | −$97.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2020-01-01 to 2020-03-31 | $68.7m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2019-07-01 to 2020-03-31 | $210.5m | us-gaap:InterestExpense |
| Income tax | 3 months, 2020-01-01 to 2020-03-31 | −$68.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2019-07-01 to 2020-03-31 | −$99.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2020-01-01 to 2020-03-31 | −$271.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2019-07-01 to 2020-03-31 | −$240.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2020-01-01 to 2020-03-31 | −$0.36 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2019-07-01 to 2020-03-31 | −$0.32 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2020-01-01 to 2020-03-31 | −$0.36 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2019-07-01 to 2020-03-31 | −$0.32 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2020-01-01 to 2020-03-31 | 760,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2019-07-01 to 2020-03-31 | 757,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2019-07-01 to 2020-03-31 | $204.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2019-07-01 to 2020-03-31 | $206.4m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 9 months, 2019-07-01 to 2020-03-31 | $195.2m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months, 2019-07-01 to 2020-03-31 | $4.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2020-03-31 | $1.28bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2020-03-31 | $3.67bn | us-gaap:AssetsCurrent |
| Total assets | at 2020-03-31 | $18.31bn | us-gaap:Assets |
| Current liabilities | at 2020-03-31 | $3.09bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2020-03-31 | $14.25bn | us-gaap:Liabilities |
| Long-term debt | at 2020-03-31 | $9.17bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2020-03-31 | $185.9m | us-gaap:DebtCurrent |
| Short-term borrowings | at 2020-03-31 | $100.0k | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2020-03-31 | $3.73bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 127,593 characters.

The following discussion and analysis of the financial condition and results of operations of Coty Inc. and its consolidated subsidiaries, should be read in conjunction with the information contained in the Condensed Consolidated Financial Statements and related notes included elsewhere in this document, and in our other public filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2019 (“Fiscal 2019 Form 10-K”). When used in this discussion, the terms “Coty,” the “Company,” “we,” “our,” or “us” mean, unless the context otherwise indicates, Coty Inc. and its majority and wholly-owned subsidiaries. Also, when used in this Quarterly Report on Form 10-Q, the term “includes” and “including” means, unless the context otherwise indicates, including without limitation. The following report includes certain non-GAAP financial measures. See “Overview—Non-GAAP Financial Measures” for a discussion of non-GAAP financial measures and how they are calculated.

All dollar amounts in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated.

More information about potential risks and uncertainties that could affect our business and financial results is included under the heading “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Quarterly Report on Form 10-Q and other periodic reports we have filed and may file with the SEC from time to time.

### Forward Looking Statements

Certain statements in this Form 10-Q are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, the impact of COVID-19 and potential recovery scenarios, the Company’s Turnaround Plan and the expansion of such plan to further reduce its cost base, strategic planning, targets, segment reporting and outlook for future reporting periods (including the extent and timing of revenue, expense and profit trends and changes in operating cash flows and cash flows from operating activities and investing activities), the strategic review of its Professional Beauty business, associated consumer hair and nail brands and Brazilian operations and any transaction related thereto, including the strategic partnership with KKR (the “Strategic Review”), including timing of such Strategic Review and any transaction and the use of proceeds from any such transaction, the issuance of preferred shares to KKR, its future operations and strategy, ongoing and future cost efficiency and restructuring initiatives and programs, strategic transactions (including their expected timing and impact), the Company’s capital allocation strategy and payment of dividends (including suspension of dividend payments and the duration thereof), investments, licenses and portfolio changes, synergies, savings, performance, cost, timing and integration of acquisitions, including the King Kylie Transaction, future cash flows, liquidity and borrowing capacity, timing and size of cash outflows and debt deleveraging, the availability of local government funding or reimbursement programs in connection with COVID-19 (including expected timing and amounts), impact and timing of supply chain disruptions and the resolution thereof, timing and extent of any future impairments, and synergies, savings, impact, cost, timing and implementation of the Company’s Turnaround Plan, including operational and organizational structure changes, segment reporting changes, operational execution and simplification initiatives, the move of the Company’s headquarters and fixed cost reductions, and the priorities of senior management. These forward-looking statements are generally identified by words or phrases, such as “anticipate”, “are going to”, “estimate”, “plan”, “project”, “expect”, “believe”, “intend”, “foresee”, “forecast”, “will”, “may”, “should”, “outlook”, “continue”, “temporary”, “target”, “aim”, “potential”, “goal” and similar words or phrases. These statements are based on certain assumptions and estimates that we consider reasonable, but are subject to a number of risks and uncertainties, many of which are beyond our control, which could cause actual events or results (including our financial condition, results of operations, cash flows and prospects) to differ materially from such statements, including risks and uncertainties relating to:

- the impact of COVID-19, including demand for the Company’s products, illness, quarantines, government actions, facility closures, store closures or other restrictions in connection with the COVID-19 pandemic, and the extent and duration thereof, related impact on our ability to meet customer needs and on the ability of third parties on which we rely, including our suppliers, customers, contract manufacturers, distributors, contractors, commercial banks, joint-venture partners, to meet their obligations to us, in particular collections from customers, the extent that government funding and reimbursement programs in connection with COVID-19 are available to us, and the ability to successfully implement measures to respond to such impacts;
- our ability to successfully implement our multi-year Turnaround Plan, including our management headquarters relocation, management realignment, reporting structure changes, segment reporting changes and the expansion of such plan to further reduce our cost base, and to develop and achieve our global business strategies (including mix management, select price increases, more disciplined promotions, and foregoing low value sales), compete effectively in the beauty industry and achieve the benefits contemplated by our strategic initiatives (including revenue growth, cost control, gross margin growth and debt deleveraging) within the expected time frame or at all;
- the result of the Strategic Review and whether such Strategic Review will result in any transactions (whether relating to all or part of the businesses in scope of the review), the timing, costs and impacts of any such transactions or divestitures, and the amount and use of proceeds from any such transactions;
- the issuance of preferred shares to KKR;
- our ability to anticipate, gauge and respond to market trends and consumer preferences, which may change rapidly, and the market acceptance of new products, including new products related to Kylie Jenner’s existing beauty business, any relaunched or rebranded products and the anticipated costs and discounting associated with such relaunches and rebrands, and consumer receptiveness to our current and future marketing philosophy and consumer engagement activities (including digital marketing and media);
- use of estimates and assumptions in preparing our financial statements, including with regard to revenue recognition, income taxes, the assessment of goodwill, other intangible assets and long-lived assets for impairment, the market value of inventory, and the fair value of assets and liabilities associated with acquisitions or divestitures;
- the impact of any future impairments;
- managerial, transformational, operational, regulatory, legal and financial risks, including diversion of management attention to and management of cash flows, expenses and costs associated with the Company's response to COVID-19, the Turnaround Plan, the Strategic Review and any related transaction, including divestiture, the integration of the King Kylie Transaction, and future strategic initiatives, and, in particular, our ability to manage and execute many initiatives simultaneously including any resulting complexity, employee attrition or diversion of resources;
- future divestitures and the impact thereof on, and future acquisitions, new licenses and joint ventures and the integration thereof with, our business, operations, systems, financial data and culture and the ability to realize synergies, avoid future supply chain and other business disruptions, reduce costs (including through our cash efficiency initiatives), avoid liabilities and realize potential efficiencies and benefits (including through our restructuring initiatives) at the levels and at the costs and within the time frames contemplated or at all;
- increased competition, consolidation among retailers, shifts in consumers’ preferred distribution and marketing channels (including to digital and luxury channels), distribution and shelf-space resets or reductions, compression of go-to-market cycles, changes in product and marketing requirements by retailers, reductions in retailer inventory levels and order lead-times or changes in purchasing patterns, impact from COVID-19 on retail revenues, and other changes in the retail, e-commerce and wholesale environment in which we do business and sell our products and our ability to respond to such changes;
- our and our joint ventures’, business partners’ and licensors’ abilities to obtain, maintain and protect the intellectual property used in our and their respective businesses, protect our and their respective reputations (including those of our and their executives or influencers) and public goodwill, and defend claims by third parties for infringement of intellectual property rights;
- any change to our capital allocation and/or cash management priorities, including any change in our stock dividend reinvestment program (the “Stock Dividend Reinvestment Program”) and dividend policy;
- any unanticipated problems, liabilities or integration or other challenges associated with a past or future acquired business, joint ventures or strategic partnerships which could result in increased risk or new, unanticipated or unknown liabilities, including with respect to environmental, competition and other regulatory, compliance or legal matters;
- our international operations and joint ventures, including enforceability and effectiveness of our joint venture agreements and reputational, compliance, regulatory, economic and foreign political risks, including difficulties and costs associated with maintaining compliance with a broad variety of complex local and international regulations;
- our dependence on certain licenses (especially in the fragrance category) and our ability to renew expiring licenses on favorable terms or at all;
- our dependence on entities performing outsourced functions, including outsourcing of distribution functions, and third-party manufacturers, logistics and supply chain suppliers, and other suppliers, including third-party software providers;
- administrative, product development and other difficulties in meeting the expected timing of market expansions, product launches and marketing efforts;
- global political and/or economic uncertainties, disruptions or major regulatory or policy changes, and/or the enforcement thereof that affect our business, financial performance, operations or products, including the impact of Brexit (and business or market disruption arising from a “hard Brexit”), the current U.S. administration, changes in the U.S. tax code, and recent changes and future changes in tariffs, retaliatory or trade protection measures, trade policies and other international trade regulations in the U.S., the European Union and Asia and in other regions where we operate;
- currency exchange rate volatility and currency devaluation;
- the number, type, outcomes (by judgment, order or settlement) and costs of current or future legal, compliance, tax, regulatory or administrative proceedings, investigations and/or litigation, including litigation relating to the tender offer by Cottage Holdco B.V. (the “Cottage Tender Offer”);
- our ability to manage seasonal factors and other variability and to anticipate future business trends and needs;
- disruptions in operations, sales and in other areas, including due to disruptions in our supply chain, restructurings and other business alignment activities, the move of our headquarters to Amsterdam, implementation of the Strategic Review, manufacturing or information technology systems, labor disputes, extreme weather and natural disasters, impact from COVID-19 and the impact of such disruptions on our ability to generate profits, stabilize or grow revenues or cash flows, comply with our contractual obligations and accurately forecast demand and supply needs and/or future results;
- restrictions imposed on us through our license agreements, credit facilities and senior unsecured bonds or other material contracts, our ability to generate cash flow to repay, refinance or recapitalize debt and otherwise comply with our debt instruments, and changes in the manner in which we finance our debt and future capital needs;
- increasing dependency on information technology, including as a result of remote working in response to COVID-19, and our ability to protect against service interruptions, data corruption, cyber-based attacks or network security breaches, costs and timing of implementation and effectiveness of any upgrades or other changes to information technology systems, and the cost of compliance or our failure to comply with any privacy or data security laws (including the European Union General Data Protection Regulation (the “GDPR”) and the California Consumer Privacy Act) or to protect against theft of customer, employee and corporate sensitive information;
- our ability to attract and retain key personnel and the impact of senior management transitions and organizational structure changes, including the co-location of key business leaders and functions in Amsterdam;
- the distribution and sale by third parties of counterfeit and/or gray market versions of our products;
- the impact of the Cottage Tender Offer and of our Turnaround Plan, and the Strategic Review and any related transactions, on our relationships with key customers and suppliers and certain material contracts;
- our relationship with Cottage Holdco B.V., as our majority stockholder, and its affiliates, and any related conflicts of interest or litigation;
- future sales of a significant number of shares by our majority stockholder or the perception that such sales could occur; and
- other factors described elsewhere in this document and in documents that we file with the SEC from time to time.

All forward-looking statements made in this document are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this document, and we do not undertake any obligation, other than as may be required by applicable law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise.

Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such, and should only be viewed as historical data.

### Industry, Ranking and Market Data

Unless otherwise indicated, information contained in this Quarterly Report on Form 10-Q concerning our industry and the markets in which we operate, including our general expectations about our industry, market position, market opportunity and market sizes, is based on data from various sources including internal data and estimates as well as third-party sources widely available to the public, such as independent industry publications, government publications, reports by market research firms or other published independent sources and on our assumptions based on that data and other similar sources. We did not fund and are not otherwise affiliated with the third-party sources that we cite. Industry publications and other published sources generally state that the information contained therein has been obtained from third-party sources believed to be reliable. Internal data and estimates are based upon information obtained from trade and business organizations and other contacts in the markets in which we operate and management’s understanding of industry conditions, and such information has not been verified by any independent sources. These data involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. While we generally believe the market, industry and other information included in this Quarterly Report on Form 10-Q to be the most recently available and to be reliable, such information is inherently imprecise and we have not independently verified any third-party information or verified that more recent information is not available.

Our fiscal year ends on June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2020” refer to the fiscal year ending June 30, 2020. Any reference to a year not preceded by “fiscal” refers to a calendar year.

### OVERVIEW

We are one of the world’s largest beauty companies, with an iconic portfolio of brands across fragrance, color cosmetics, hair color and styling, and skin and body care. We are the global leader in fragrance, a strong number two in professional hair color & styling, and number three in color cosmetics. The transformational acquisition of The Procter & Gamble Company’s beauty business (the “P&G Beauty Business”) and our other strategic transactions, including the King Kylie Transaction, have strengthened and diversified our presence across the countries, categories and channels in which we compete, building a strong beauty platform. Our products are sold in more than 150 countries around the world.

The recent developments surrounding the COVID-19 pandemic are having material effects on all of our product categories across all segments and geographies. The unprecedented containment measures adopted worldwide to address the pandemic have contributed to a significant decline in volume trends. In particular, demand for prestige products mainly sold in retail malls, professional salon products, and the travel retail channel have been more significantly impacted by temporary closures of non-essential businesses and social distancing measures. Many of our mass products are offered in other channels, such as drug and grocery stores, that continue to operate as essential businesses. However, shelter-in-place orders, reduced store hours, and other social distancing measures have resulted in reduced customer traffic and sales volumes for these product categories as well.

In response to the COVID-19 pandemic, we have implemented several key measures. To mitigate closures of our existing sales channels, open channels and markets are being prioritized, with the acceleration of several initiatives such as e-commerce. We have also taken aggressive steps to reduce operating costs to more appropriately align with the current sales volume trends. Such measures include slowing down our production to adjust our inventories, the recently announced temporary compensation reductions for certain executives and for our non-executive board members, hiring and travel restrictions, temporary furloughs for certain employees and the reduction of advertising and consumer promotion costs for sales channels that are closed or heavily impacted by social distancing. We intend to utilize any tax payment deferrals that apply to us in specific jurisdictions. We will actively manage our working capital to support our liquidity needs. Additionally, to address the potentially longer-lasting impacts of the COVID-19, the lockdown and a possible recession resulting from COVID-19 in many markets, we will be implementing a plan to reduce our cost base, which does not vary with revenues, by 25%, including an adaptation of our supply network and organization as well as a reduction of certain discretionary expenses.

We anticipate a continued decline in period over period volume trends until such containment measures are discontinued and normal consumer traffic resumes. We currently expect that any easing of containment measures and recovery of the impacted sectors of the economy will be gradual. As a result, we anticipate that consumer spending habits and consumer confidence will continue to shift, causing future sales and volume trends to be non-linear. After the resumption of more typical business conditions, the economics of developing, producing, launching, supporting and discontinuing products will continue to impact the timing of our sales and operating performance each period. In addition, as product life cycles shorten, results are driven primarily by successfully developing, introducing and marketing new, innovative products.

#### Strategic Review Update

On May 11, 2020, we announced that as a result of the Company’s previously announced Strategic Review that we signed a Memorandum of Understanding (“MOU”) with KKR for the sale of a 60% interest in our Professional Beauty business and retail hair brands, including *OPI* and *ghd (“*the PB Sale”), at an enterprise value of $4,300.0. Under the terms of the MOU, the Company agreed to exclusively negotiate a definitive agreement with respect to the PB Sale with KKR. Upon reaching such agreement, Coty will carve out such business into a standalone company in which KKR will acquire a 60% stake and Coty will retain the remaining 40% interest. On signing of the PB Sale transaction, KKR will make an incremental convertible preferred investment of $250.0 in Coty.

#### Turnaround Plan Update

In July 2019, we commenced our multi-year Turnaround Plan, which aims to stabilize and gradually accelerate revenue growth, improve our profitability through gross margin growth and cost control, and deleverage our balance sheet. In connection with the Turnaround Plan, we also announced organizational changes to reduce geographic fragmentation and costs, including the co-location of most of our executive team and corporate functions in a centralized management headquarters in Amsterdam, which is expected to host approximately several hundred roles (largely impacting our London, Geneva and New York operations). On May 11, 2020, we announced an expansion of the Turnaround Plan. As part of this expansion, we plan to implement a 25% reduction of our cost base, which does not vary with revenues, by the end of fiscal 2023, including reprioritizing projects providing larger cost reduction benefits, an adaptation of our supply network and organization as well as a reduction of certain discretionary expenses. The expansion is designed to adjust our cost base to allow us to exit the post-COVID recovery phase as a financially and operationally stronger, more nimble company, which is well positioned to capture growth opportunities. We expect to incur cash costs consistent with the previously announced estimate.

In connection with these organizational initiatives, we have also changed the reporting structure used to allocate resources from the previous category focused organizational structure to a structure based on regional commercial business units. These segment changes were implemented during the three months ended March 31, 2020. As a result of these changes, the Company has four operating segments and reportable segments: Europe, Middle East & Africa (“EMEA”), Americas, Asia Pacific, and Professional Beauty. EMEA, Americas and Asia Pacific include the businesses focused on prestige fragrances, premium skin care, premium color cosmetics, mass color cosmetics, retail hair coloring and styling products, mass fragrance, mass skin care and body care, and are supported by central marketing teams. We have changed the reporting of our results to reflect the changes in our reportable segments.

These organizational, business and structural changes are still being operationalized, which introduces additional complexity as we roll out several initiatives simultaneously, such as our Strategic Review.

We continue to be in the early stages of implementing our Turnaround Plan. Exclusive of the effects of the COVID-19 pandemic, which became more evident in the latter portion of the quarter, our global share trends in the mass color cosmetics categories in which we compete continue to decline. However, *CoverGirl’*s top franchises have experienced market share improvements. In addition, *Sally Hansen* continues to experience positive trends. These improvements reflect turnaround plan actions including improved promotional activity, improved product assortment and proactive initiatives to reduce product diversion through lower priced distribution channels and execution of price increases in certain products for certain geographies.

Our strategy to focus on the fragrance, color cosmetics and skin care categories, with the goal of stabilizing the mass beauty business and amplifying the performance of the prestige business, is underway. The King Kylie Transaction, the divestiture of the Younique business and the outcome of our Strategic Review, as noted above, are reflections of our intent to focus on our core go-to-market competencies and to simultaneously deleverage our balance sheet.

#### Non-GAAP Financial Measures

To supplement the financial measures prepared in accordance with GAAP, we use non-GAAP financial measures including Adjusted operating income, Adjusted net income attributable to Coty Inc. and Adjusted net income attributable to Coty Inc. per common share (collectively, the “Adjusted Performance Measures”). The reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are shown in the tables below. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Three Months Ended March 31, 2020 As Compared To Three Months Ended March 31, 2019 and Nine Months Ended March 31, 2020 As Compared To Nine Months Ended March 31, 2019.” These non-GAAP financial measures should not be considered in isolation from, or as a substitute for or superior to, financial measures reported in accordance with GAAP. Moreover, these non-GAAP financial measures have limitations in that they do not reflect all the items associated with the operations of the business as determined in accordance with GAAP. Other companies, including companies in the beauty industry, may calculate similarly titled non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.

Despite the limitations of these non-GAAP financial measures, our management uses the Adjusted Performance Measures as key metrics in the evaluation of our performance, preparation of our annual budgets and to benchmark performance of our business against our competitors. The following are examples of how these Adjusted Performance Measures are utilized by our management:

- strategic plans and annual budgets are prepared using the Adjusted Performance Measures;
- senior management receives a monthly analysis comparing budget to actual operating results that is prepared using the Adjusted Performance Measures; and
- senior management’s annual compensation is calculated, in part, by using some of the Adjusted Performance Measures.

In addition, our financial covenant compliance calculations under our debt agreements are substantially derived from these Adjusted Performance Measures.

Our management believes that Adjusted Performance Measures are useful to investors in their assessment of our operating performance and the valuation of the Company. In addition, these non-GAAP financial measures address questions we routinely receive from analysts and investors and, in order to ensure that all investors have access to the same data, our management has determined that it is appropriate to make this data available to all investors. The Adjusted Performance Measures exclude the impact of certain items (as further described below) and provide supplemental information regarding our operating performance. By disclosing these non-GAAP financial measures, our management intends to provide investors with a supplemental comparison of our operating results and trends for the periods presented. Our management believes these measures are also useful to investors as such measures allow investors to evaluate our performance using the same metrics that our management uses to evaluate past performance and prospects for future performance. We provide disclosure of the effects of these non-GAAP financial measures by presenting the corresponding measure prepared in conformity with GAAP in our financial statements, and by providing a reconciliation to the corresponding GAAP measure so that investors may understand the adjustments made in arriving at the non-GAAP financial measures and use the information to perform their own analyses.

Adjusted operating income excludes restructuring costs and business structure realignment programs, amortization, acquisition-related costs and acquisition accounting impacts, asset impairment charges and other adjustments as described below. We do not consider these items to be reflective of our core operating performance due to the variability of such items from period-to-period in terms of size, nature and significance. They are primarily incurred to realign our operating structure and integrate new acquisitions, and fluctuate based on specific facts and circumstances. Additionally, Adjusted net income attributable to Coty Inc. and Adjusted net income attributable to Coty Inc. per common share are adjusted for certain interest and other (income) expense as described below and the related tax effects of each of the items used to derive Adjusted net income as such charges are not used by our management in assessing our operating performance period-to-period.

Adjusted Performance Measures reflect adjustments based on the following items:

- Costs related to acquisition and divestiture activities: We have excluded acquisition and divestiture-related costs and the accounting impacts such as those related to transaction costs and costs associated with the revaluation of acquired inventory in connection with business combinations because these costs are unique to each transaction. The nature and amount of such costs vary significantly based on the size and timing of the acquisitions and divestitures, and the maturities of the businesses being acquired or divested. Also, the size, complexity and/or volume of past transactions, which often drives the magnitude of such expenses, may not be indicative of the size, complexity and/or volume of any future acquisitions or divestitures.
- Restructuring and other business realignment costs: We have excluded costs associated with restructuring and business structure realignment programs to allow for comparable financial results to historical operations and forward-looking guidance. In addition, the nature and amount of such charges vary significantly based on the size and timing of the programs. By excluding the referenced expenses from our non-GAAP financial measures, our management is able to further evaluate our ability to utilize existing assets and estimate their long-term value. Furthermore, our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
- Asset impairment charges: We have excluded the impact of asset impairments as such non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
- Gain on sale of business: We have excluded the impact of the Gain on sale of business as such amounts are inconsistent in amount and frequency and are significantly impacted by the size of divestitures. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance.
- Amortization expense: We have excluded the impact of amortization of finite-lived intangible assets, as such non-cash amounts are inconsistent in amount and frequency and are significantly impacted by the timing and/or size of acquisitions. Our management believes that the adjustment of these items supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance. Although we exclude amortization of intangible assets from our non-GAAP expenses, our management believes that it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in the amortization of additional intangible assets.
- Other expense: We have excluded the impact of costs incurred for legal and advisory services rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders. Our management believes these costs do not reflect our underlying ongoing business, and the adjustment of such costs helps investors and others compare and analyze performance from period to period. We have also excluded the impact of pension curtailment (gains) and losses and pension settlements as such events are triggered by our restructuring and other business realignment activities and the amount of such charges vary significantly based on the size and timing of the programs.
- Noncontrolling interests: This adjustment represents the after-tax impact of the non-GAAP adjustments included in Net income attributable to noncontrolling interests based on the relevant noncontrolling interest percentage.
- Tax: This adjustment represents the impact of the tax effect of the pretax items excluded from Adjusted net income. The tax impact of the non-GAAP adjustments is based on the tax rates related to the jurisdiction in which the adjusted items are received or incurred.

While acquiring brands and licenses comprises a part of our overall growth strategy, along with targeting organic growth opportunities, we have excluded acquisition-related costs and acquisition accounting impacts in connection with business combinations because these costs are unique to each transaction and the amount and frequency are not consistent and are significantly impacted by the timing and size of our acquisitions. Our management assesses the success of an acquisition as a component of performance using a variety of indicators depending on the size and nature of the acquisition, including:

- the scale of the combined company by evaluating consolidated and segment financial metrics;
- the expansion of product offerings by evaluating segment, brand, and geographic performance and the respective strength of the brands;
- the evaluation of share expansion in categories and geographies;
- the earnings per share accretion and substantial incremental free cash flow generation providing financial flexibility for us; and
- the comparison of actual and projected results, including achievement of projected synergies, post integration; provided that timing for any such comparison will depend on the size and complexity of the acquisition.

#### Constant Currency

We operate on a global basis, with the majority of our net revenues generated outside of the U.S. Accordingly, fluctuations in foreign currency exchange rates can affect our results of operations. Therefore, to supplement financial results presented in accordance with GAAP, certain financial information is presented in “constant currency”, excluding the impact of foreign currency exchange translations to provide a framework for assessing how our underlying businesses performed excluding the impact of foreign currency exchange translations. Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We calculate constant currency information by translating current and prior-period results for entities reporting in currencies other than U.S. dollars into U.S. dollars using prior year foreign currency exchange rates. The constant currency calculations do not adjust for the impact of revaluing specific transactions denominated in a currency that is different to the functional currency of that entity when exchange rates fluctuate. The constant currency information we present may not be comparable to similarly titled measures reported by other companies.

#### Basis of Presentation of Acquisitions, Divestitures and Terminations

During the period when we complete an acquisition, divestiture or early license termination, the financial results of the current year period are not comparable to the financial results presented in the prior year period. When explaining such changes from period to period and to maintain a consistent basis between periods, we exclude the financial contribution of: (i) the acquired brands or businesses in the current year period until we have twelve months of comparable financial results and (ii) the divested brands or businesses or early terminated brands, generally, in the prior year non-comparable periods, to maintain comparable financial results with the current fiscal year period. Acquisitions, divestitures and early license terminations that would impact the comparability of financial results between periods presented in the Management’s Discussion and Analysis of Financial Condition and Results of Operations are shown in the table below.

| Period of acquisition, divestiture, or termination | Acquisition, divestiture, or termination | Impact on basis of presentation |
| --- | --- | --- |
| **First quarter fiscal 2020** | Divestiture: Younique - the divestiture of the interest in Foundation, which holds the net assets for Younique | September fiscal year 2020 and September - March fiscal year 2019 financial contribution excluded. Closing date of divestiture was September 16, 2019. This effectively excludes the incremental three months and 14 days of net revenue contribution from Younique in the prior year. |
| **Third quarter fiscal 2020** | Acquisition: King Kylie Transaction - the acquisition of 51% interest in King Kylie LLC | Third quarter fiscal year 2020 financial contribution excluded. |

When used herein, the term “Acquisitions” and “Divestitures” or "Acquisition" and “Divestiture”, as applicable, refer to the financial contributions of the related acquisitions or divestitures and early license terminations shown above, during the period that is not comparable as a result of such acquisitions or divestitures and early license terminations.

### THREE MONTHS ENDED MARCH 31, 2020 AS COMPARED TO THREE MONTHS ENDED MARCH 31, 2019

NET REVENUES

In the three months ended March 31, 2020, net revenues decreased 23%, or $462.6, to $1,528.0 from $1,990.6 in the three months ended March 31, 2019. Excluding the impact of the Acquisition and the Divestiture, total net revenues decreased 22%, or $412.9, to $1,491.0 in the three months ended March 31, 2020 from $1,903.9 in the three months ended March 31, 2019, reflecting a decrease in unit volume of 18%, a negative foreign currency exchange translation impact of 2%, and a negative price and mix impact of 2%. The decrease in net revenues primarily reflects lower net revenues due to the COVID-19 pandemic, impacting all product categories across the Company, with the highest impact on the prestige products, professional products, mass color cosmetics and retail hair, due to the closure of retail malls, professional salons, travel retail channels and certain mass channels. *Calvin Klein, Gucci, Hugo Boss, Burberry* and *Wella Professional* were prestige and professional brands with the highest net revenue decrease. The impact to the mass category brands sold in drug and grocery stores, although significant due to social distancing directives, was relatively mitigated due to these distribution channels mostly remaining open. The corresponding net revenue declines in the mass channel were mainly seen in *CoverGirl, Rimmel, Max Factor* and *Bourjois.*

### Net Revenues by Segment

*(in millions)*

| NET REVENUES | Three Months Ended March 31, 2020 | 2019 | Change % |
| --- | ---: | ---: | ---: |
| Americas | $492.6 | $581.6 | (15)% |
| EMEA | 550.6 | 705.6 | (22)% |
| Asia Pacific | 124.7 | 197.7 | (37)% |
| Professional Beauty | 360.1 | 419.0 | (14)% |
| Other | — | 86.7 | (100)% |
| **Total** | **$1,528.0** | **$1,990.6** | **(23)%** |

#### Americas

In the three months ended March 31, 2020, net revenues from the Americas segment decreased 15%, or $89.0 to $492.6 compared to $581.6 in the three months ended March 31, 2019. Excluding the impact of the Acquisition, net revenues from the Americas segment decreased 22%, or $126.0, to $455.6 in the three months ended March 31, 2020, from $581.6 in the three months ended March 31, 2019 reflecting a decrease in unit volume of 21% and a negative foreign currency exchange translation impact of 3%, offset by a positive price and mix impact of 2%. The decrease in net revenues primarily reflects:

(i) lower net revenues due to the COVID-19 pandemic, impacting all product categories across the segment due to the closure of retail malls, professional salons, travel retail channels and certain mass channels. *Calvin Klein, philosophy, Gucci, Burberry* and *Marc Jacobs* were prestige brands with the highest net revenue decrease. The impact to the mass category brands sold in drug and grocery stores, although significant due to social distancing directives, was relatively mitigated due to these distribution channels mostly remaining open. The corresponding net revenue declines in the mass channel were mainly seen in *CoverGirl* and *Rimmel;*

(ii) shelf-space losses in the United States primarily impacting *CoverGirl, Rimmel* and *philosophy* which have contributed to the negative share trends in mass color cosmetics and prestige skin products; and

(iii) negative category trends in the United States for mass color cosmetics and mass fragrances.

These decreases were partially offset by increased net revenues from *Sally Hansen* due to continued success across its core sub-brands as well as incremental net revenues from the launch of *Sally Hansen Good.Kind.Pure.*

#### EMEA

In the three months ended March 31, 2020, net revenues from the EMEA segment decreased 22%, or $155.0, to $550.6 from $705.6 in the three months ended March 31, 2019, reflecting a decrease in unit volume of 14%, a negative foreign currency exchange translation impact of 2%, and a negative price and mix impact of 6%. The decrease in net revenues primarily reflects:

(i) lower net revenues due to the COVID-19 pandemic, impacting all product categories across the segment, primarily in Italy, Spain and the Middle East, with the highest impact on prestige products due to the closure of retail malls and travel retail channels. *Calvin Klein, Hugo Boss,* and *Gucci* were prestige brands with the highest net revenue decrease. The impact to the mass category brands sold in drug and grocery stores, although significant due to social distancing directives, was relatively mitigated due to these distribution channels mostly remaining open. The corresponding net revenue declines in the mass channel were mainly seen in *Bourjois, Rimmel, Max Factor* and the retail line of *Wella;*

(ii) negative share trends in Europe for mass color cosmetics partially due to a strategic decision to withdraw *Bourjois* in the UK and negative share trends for hair color;

(iii) negative category trends in Europe for mass color cosmetics and hair color impacting *Bourjois* and the retail hair line of *Wella*; and

(iv) declines in *adidas, Rimmel, Bourjois, Max Factor* and mass fragrances due to a renegotiation with key third party distributors in the Middle East and strategic distribution limits in Africa.

These decreases were partially offset by net revenue increases in Russia from the growth of a key mass retail customer.

#### Asia Pacific

In the three months ended March 31, 2020, net revenues from the Asia Pacific segment decreased 37%, or $73.0, to $124.7 from $197.7 in the three months ended March 31, 2019, reflecting a decrease in unit volume of 32%, a negative foreign currency exchange translation impact of 2%, and a negative price and mix impact of 3%. The decrease in net revenues primarily reflects lower net revenues due to the COVID-19 pandemic, impacting all product categories across the segment, primarily in China, with the highest impact on the prestige category due to the closure of retail malls and travel retail channels. *Gucci, Calvin Klein, Burberry* and *Miu Miu* were prestige brands with the highest net revenue decrease. The impact to the mass category brands sold in drug and grocery stores, although significant due to social distancing directives, was relatively mitigated due to these distribution channels mostly remaining open. The corresponding net revenue declines in the mass channel were mainly seen in *Max Factor, adidas* and *Rimmel.*

#### Professional Beauty

In the three months ended March 31, 2020, net revenues from the Professional Beauty segment decreased 14%, or $58.9, to $360.1 from $419.0 in the three months ended March 31, 2019, reflecting a decrease in unit volume of 13% and a negative foreign currency exchange translation impact of 2%, offset by a positive in price and mix impact of 1%. The decrease in net revenues primarily reflects lower net revenues due to the COVID-19 pandemic, with the highest impact on *Wella Professional* and *OPI*. These decreases were partially offset by increased net revenues from *ghd* due to continued success from the launches of *ghd Glide* and *ghd Oracle*, as well as increased *ghd* e-commerce sales.

#### Other

Other consists of the prior period net revenues from the Divestiture of Younique.

COST OF SALES

In the three months ended March 31, 2020, cost of sales decreased 17%, or $124.1, to $617.1 from $741.2 in the three months ended March 31, 2019. Cost of sales as a percentage of net revenues increased to 40.4% in the three months ended March 31, 2020 from 37.2% in the three months ended March 31, 2019, resulting in a gross margin decrease of approximately 320 basis points, primarily reflecting:

(i) incremental expense of underutilized facilities costs due to reduced sales volume resulting from the COVID-19 pandemic;

(ii) increased excess and obsolescence expense on inventory, primarily in the Americas and EMEA segments mainly impacting prestige products, due to the COVID-19 pandemic impacting demand;

(iii) negative foreign currency exchange on imported materials, primarily impacting Brazil; and

(iv) negative gross margin impacts from the Divestiture due to prior year margin benefits provided by Younique.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

In the three months ended March 31, 2020, selling, general and administrative expenses decreased 7%, or $71.4, to $999.1 from $1,070.5 in the three months ended March 31, 2019. Selling, general and administrative expenses as a percentage of net revenues increased to 65.4% in the three months ended March 31, 2020 from 53.8% in the three months ended March 31, 2019, or approximately 1160 basis points. This increase primarily reflects:

(i) 490 basis points related to higher administrative costs as a percentage of net revenue as the compensation expense savings from prior restructuring programs were out-paced by the decline in net revenues;

(ii) 210 basis points related to higher negative transactional impact from our exposure to foreign currency exchange fluctuations;

(iii) 150 basis points related to higher advertising and consumer promotion costs as a percentage of net revenues as the savings in media and promotional trade spending from the COVID-19 pandemic were out-paced by the decline in net revenues;

(iv) 140 basis points related to higher share-based compensation due to significant executive forfeitures of share-based compensation instruments in the prior year;

(v) 40 basis points related to lower logistics costs due to prior year integration costs, outpaced by the decline in the net revenues;

(vi) 30 basis points related to higher bad debt expense; and

(vii) 100 basis points related to other expenses, primarily related to costs associated with our business realignment.

OPERATING INCOME (LOSS)

In the three months ended March 31, 2020, operating loss was $258.8 compared to income of $85.5 in the three months ended March 31, 2019. Operating margin, or operating loss as a percentage of net revenues, decreased to (16.9)% in the three months ended March 31, 2020 as compared to an operating income as a percentage of net revenues of 4.3% in the three months ended March 31, 2019. The operating margin declines are largely driven by the reduced sales volume due to the COVID-19 pandemic impacting demand, increased cost of sales and increased selling, general and administrative expenses as a percentage of net revenues in the current year, in addition to increased acquisition and divestiture related expenses, asset impairment charges and amortization expense as a percentage of net revenues.

### Operating Income by Segment

*(in millions)*

| Operating income (loss) | Three Months Ended March 31, 2020 | 2019 | Change % |
| --- | ---: | ---: | --- |
| Americas | $(16.8) | $36.4 | \<(100%) |
| EMEA | (47.4) | 53.8 | \<(100%) |
| Asia Pacific | (24.7) | 22.4 | \<(100%) |
| Professional Beauty | 2.1 | 33.0 | (94)% |
| Other | — | (2.9) | 100% |
| Corporate | (172.0) | (57.2) | \<(100%) |
| **Total** | **$(258.8)** | **$85.5** | **\<(100%)** |

#### Americas

In the three months ended March 31, 2020, operating loss for Americas was $16.8 compared to an income of $36.4 in the three months ended March 31, 2019. Operating margin decreased to (3.4)% of net revenues in the three months ended March 31, 2020 as compared to 6.3% in the three months ended March 31, 2019, driven by reduced sales volume due to the COVID-19 pandemic impacting demand, higher cost of goods sold as a percentage of net revenues, higher selling, general and administrative expenses as a percentage of net revenues, and higher amortization expense as a percentage of net revenues.

#### EMEA

In the three months ended March 31, 2020, operating loss for EMEA was $47.4 compared to an income of $53.8 in the three months ended March 31, 2019. Operating margin decreased to (8.6)% of net revenues in the three months ended March 31, 2020 as compared to 7.6% in the three months ended March 31, 2019, driven by reduced sales volume due to the COVID-19 pandemic impacting demand, higher cost of goods sold as a percentage of net revenues, higher selling, general and administrative expenses as a percentage of net revenues, and higher amortization expense as a percentage of net revenues.

#### Asia Pacific

In the three months ended March 31, 2020, operating loss for Asia Pacific was $24.7 compared to an income of $22.4 in the three months ended March 31, 2019. Operating margin decreased to (19.8)% of net revenues in the three months ended March 31, 2020 as compared to 11.3% in the three months ended March 31, 2019, primarily driven by reduced sales volume due to the COVID-19 pandemic impacting demand, higher selling and general administrative costs as a percentage of net revenues, partially offset by lower cost of goods sold as a percentage of net revenues.

#### Professional Beauty

In the three months ended March 31, 2020, operating income for Professional Beauty was $2.1 compared to an income of $33.0 in the three months ended March 31, 2019. Operating margin decreased to 0.6% of net revenues in the three months ended March 31, 2020 as compared to 7.9% in the three months ended March 31, 2019, driven by reduced sales volume due to the COVID-19 pandemic impacting demand, higher cost of goods sold as a percentage of net revenues, higher selling, general and administrative expenses as a percentage of net revenues, and higher amortization expense as a percentage of net revenues.

#### Other

Other represents operating income (loss) from the Divestiture of Younique.

#### Corporate

Corporate primarily includes income and expenses not directly relating to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.

In the three months ended March 31, 2020, the operating loss for Corporate was $172.0 compared to a loss of $57.2 in the three months ended March 31, 2019, as described under “Adjusted Operating Income for Coty Inc.” below. The decrease to operating loss for Corporate was primarily driven by an increase in acquisition and divestiture related costs, increase in restructuring and other business realignment costs and asset impairment charges incurred in the current year.

### Adjusted Operating Income (loss) by Segment

We believe that adjusted operating income (loss) by segment further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” A reconciliation of reported operating income (loss) to adjusted operating income is presented below, by segment:

*(in millions)*

| Operating (loss) income | Three Months Ended March 31, 2020 Reported (GAAP) | Adjustments (a) | Adjusted (Non-GAAP) |
| --- | ---: | ---: | ---: |
| Americas | $(16.8) | $(29.7) | $12.9 |
| EMEA | (47.4) | (33.6) | (13.8) |
| Asia Pacific | (24.7) | (7.1) | (17.6) |
| Professional Beauty | 2.1 | (17.2) | 19.3 |
| Other | — | — | — |
| Corporate | (172.0) | (171.3) | (0.7) |
| **Total** | **$(258.8)** | **$(258.9)** | **$0.1** |

45

*(in millions)*

| Operating income (loss) | Three Months Ended March 31, 2019 Reported (GAAP) | Adjustments (a) | Adjusted (Non-GAAP) |
| --- | ---: | ---: | ---: |
| Americas | $36.4 | $(20.0) | $56.4 |
| EMEA | 53.8 | (34.5) | 88.3 |
| Asia Pacific | 22.4 | (6.8) | 29.2 |
| Professional Beauty | 33.0 | (16.7) | 49.7 |
| Other | (2.9) | (8.5) | 5.6 |
| Corporate | (57.2) | (57.5) | 0.3 |
| **Total** | **$85.5** | **$(144.0)** | **$229.5** |

(a) See a reconciliation of reported operating income to adjusted operating income and a description of the adjustments under “Adjusted Operating Income for Coty Inc.” below. All adjustments are reflected in Corporate, except for amortization and asset impairment charges on goodwill, regional indefinite-lived intangible assets, and finite-lived intangible assets, which are reflected in the Americas, EMEA, Asia Pacific, Professional Beauty and Other segments.

### Adjusted Operating Income for Coty Inc.

We believe that adjusted operating income (loss) further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” Reconciliation of reported operating income to adjusted operating income is presented below:

*(in millions)*

|  | Three Months Ended March 31, 2020 | 2019 | Change % |
| --- | ---: | ---: | ---: |
| **Reported operating income (loss)** | **$(258.8)** | **$85.5** | **\<(100%)** |
| % of net revenues | (16.9)% | 4.3% |  |
| Amortization expense | 87.6 | 86.7 | 1% |
| Restructuring and other business realignment costs | 81.6 | 57.3 | 42% |
| Acquisition and divestiture-related costs | 49.3 | — | N/A |
| Asset impairment charges | 40.4 | — | N/A |
| Total adjustments to reported operating income | $258.9 | $144.0 | 80% |
| **Adjusted operating income** | **$0.1** | **$229.5** | **(100)%** |
| % of net revenues | —% | 11.5% |  |

In the three months ended March 31, 2020, adjusted operating income decreased approximately 100%, or $229.4 to $0.1 from $229.5 in the three months ended March 31, 2019. Adjusted operating margin decreased to nil % of net revenues in the three months ended March 31, 2020 from 11.5% in the three months ended March 31, 2019, primarily driven by reduced net revenues due to the COVID-19 pandemic, higher selling, general and administrative costs as a percentage of net revenues and higher cost of goods sold as a percentage of net revenues. Excluding the impact of foreign currency exchange translations, adjusted operating income decreased approximately 99%.

#### Amortization Expense

In the three months ended March 31, 2020, amortization expense increased to $87.6 from $86.7 in the three months ended March 31, 2019. In the three months ended March 31, 2020, amortization expense of $29.7, $33.6, $7.1, $17.2, and $0.0 was reported in the Americas, EMEA, Asia Pacific, Professional Beauty and Other segments, respectively. In three months ended March 31, 2019, amortization expense of $20.0, $34.6, $6.9, $16.7, and $8.5 was reported in the Americas, EMEA, Asia Pacific, Professional Beauty and Other segments, respectively.

#### Restructuring and Other Business Realignment Costs

We continue to analyze our cost structure, including opportunities to simplify and optimize operations. On July 1, 2019, we announced our Turnaround Plan. To implement the Turnaround Plan, we expect to incur restructuring and other business realignment costs, in addition to costs associated with previously announced programs. The Company expects incremental cash costs related to the Turnaround Plan to be approximately $600.0. In addition, the Company will continue to incur cash costs of $160.0 related to restructuring and other business realignment costs connected to previously announced programs. During the three months ended March 31, 2020 we spent approximately $76.0 in connection with the execution of the Turnaround Plan and our previously announced programs.

Prior to July 1, 2019, we incurred restructuring and related costs aimed at integrating and optimizing the combined organization following the acquisition of the P&G Beauty Business, which we refer to as the Global Integration Activities, and reducing fixed costs and enabling further investment in the business, which we refer to as the 2018 Restructuring Actions.

In the three months ended March 31, 2020, we incurred restructuring and other business structure realignment costs of $81.6, as follows:

- We incurred restructuring savings of $(6.7) primarily related to changes in estimate in our restructuring plans, partially offset by additional costs related to the Turnaround Plan, included in the Condensed Consolidated Statements of Operations; and
- We incurred business structure realignment costs of $88.3 primarily related to the Turnaround Plan and certain other programs. This amount includes $77.1 reported in selling, general and administrative expenses, primarily related to severance, consulting costs and accelerated depreciation costs; and $11.2 reported in cost of sales in the Condensed Consolidated Statement of Operations.

In the three months ended March 31, 2019, we incurred restructuring and other business structure realignment costs of $57.3 as follows:

- We incurred restructuring costs of $6.7 primarily related to the Global Integration Activities, included in the Condensed Consolidated Statements of Operations; and
- We incurred business structure realignment costs of $50.6 primarily related to our Global Integration Activities and certain other programs. This amount includes $48.4 reported in selling, general and administrative expenses and $2.2 reported in cost of sales in the Condensed Consolidated Statements of Operations, primarily due to costs incurred for the realignment of the business due to the P&G Beauty Business.

In all reported periods, all restructuring and other business realignment costs were reported in Corporate.

#### Acquisition and Divestiture Activities

In the three months ended March 31, 2020 we incurred $49.3 of costs related to acquisition and divestiture activities. These costs were partially driven by consulting and legal fees associated with the King Kylie purchase agreement, as well as consulting and legal fees associated with the process to explore strategic alternatives, including divestment, for the Professional Beauty business including associated hair brands sold by the Americas, EMEA and Asia Pacific segments, as well as the Company’s Brazilian operations.

In the three months ended March 31, 2019 there were no acquisition or divestiture-related charges incurred.

In all reported periods, all costs related to acquisition and divestiture activities were reported in Corporate.

#### Asset Impairment Charges

In the three months ended March 31, 2020 we incurred asset impairment charges of $40.4 in Corporate, relating to indefinite-lived other intangible assets (related to the *CoverGirl, Max Factor* and *Bourjois* trademarks).

In the three months ended March 31, 2019, we did not incur any asset impairment charges.

INTEREST EXPENSE, NET

In the three months ended March 31, 2020, net interest expense was $73.6 as compared with $72.0 in the three months ended March 31, 2019. This increase is primarily due to the impact of transactional foreign exchange.

INCOME TAXES

The effective income tax rate for the three months ended March 31, 2020 and 2019 was 20.6% and 0.0%, respectively. The change in the effective tax rate for the three months ended March 31, 2020, as compared to the three months ended March 31, 2019, is primarily due to the resolution of foreign uncertain tax positions in the prior period.

The effective income tax rates vary from the U.S. federal statutory rate of 21% due to the effect of (i) jurisdictions with different statutory rates, (ii) adjustments to our unrealized tax benefits (“UTBs”) and accrued interest, (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.

On March 27, 2020, the United States government passed the Coronavirus Aid, Relief, and Economic Security Act (the "CARES" Act). The Company has analyzed the provisions, which include modifications to net operating loss limitations, modifications to the deductibility of business interest expense, as well as Alternative Minimum Tax ("AMT") credit acceleration, and interim reporting considerations and there is no impact to the current quarter.

### Reconciliation of Reported (Loss) Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:

*(in millions)*

|  | Three Months Ended March 31, 2020 (Loss) Income Before Income Taxes | (Benefit) Provision for Income Taxes | Effective Tax Rate | Three Months Ended March 31, 2019 (Loss) Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **Reported (loss) before income taxes** | **$(332.9)** | **$(68.5)** | **20.6%** | **$(4.0)** | **$—** | **—%** |
| Adjustments to reported operating income (a) (b) | 258.9 | 52.1 |  | 144.0 | 38.6 |  |
| Other adjustments (b)(c) | — | — |  | 12.7 | 0.8 |  |
| **Adjusted income before income taxes** | **$(74.0)** | **$(16.4)** | **22.2%** | **$152.7** | **$39.4** | **25.8%** |

(a) See a description of adjustments under “Adjusted Operating Income for Coty Inc.”

(b) The tax effects of each of the items included in adjusted income are calculated in a manner that results in a corresponding income tax expense/provision for adjusted income. In preparing the calculation, each adjustment to reported income is first analyzed to determine if the adjustment has an income tax consequence. The provision for taxes is then calculated based on the jurisdiction in which the adjusted items are incurred, multiplied by the respective statutory rates and offset by the increase or reversal of any valuation allowances commensurate with the non-GAAP measure of profitability.

(c) In the three months ended March 31, 2019, the Company incurred legal and advisory services of $12.7 rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders.

The adjusted effective tax rate was 22.2% for the three months ended March 31, 2020 compared to 25.8% for the three months ended March 31, 2019. The differences were primarily due to the jurisdictional mix of income.

NET INCOME (LOSS) ATTRIBUTABLE TO COTY INC.

Net income (loss) attributable to Coty Inc. was a loss of $271.6 in the three months ended March 31, 2020 as compared to a loss of $12.1 in the three months ended March 31, 2019. This increase primarily reflects the increased restructuring and other business realignment costs and acquisition and divestiture related costs as well as asset impairment charges incurred in the current period.

We believe that adjusted net income (loss) attributable to Coty Inc. provides an enhanced understanding of our performance. See “Overview—Non-GAAP Financial Measures.”

*(in millions)*

|  | Three Months Ended March 31, 2020 | 2019 | Change % |
| --- | ---: | ---: | --- |
| **Reported net (loss) attributable to Coty Inc.** | **$(271.6)** | **$(12.1)** | **\<(100%)** |
| % of net revenues | (17.8)% | (0.6)% |  |
| Adjustments to reported operating income (a) | 258.9 | 144.0 | 80% |
| Adjustment to other expense (b) | — | 12.7 | N/A |
| Adjustments to noncontrolling interests (b) | 3.1 | (3.6) | \>100% |
| Change in tax provision due to adjustments to reported net income attributable to Coty Inc. | (52.1) | (39.4) | (32)% |
| **Adjusted net income (loss) attributable to Coty Inc.** | **$(61.7)** | **$101.6** | **\<(100%)** |
| % of net revenues | (4.0)% | 5.1% |  |
| **Per Share Data** |  |  |  |
| Adjusted weighted-average common shares |  |  |  |
| Basic | 760.8 | 751.4 |  |
| Diluted | 760.8 | 753.9 |  |
| Adjusted net income attributable to Coty Inc. per common share |  |  |  |
| Basic | $(0.08) | $0.14 |  |
| Diluted | (0.08) | 0.13 |  |

(a) See a description of adjustments under “Adjusted Operating Income for Coty Inc.”

(b) The amounts represent the after-tax impact of the non-GAAP adjustments included in Net income attributable to noncontrolling interest based on the relevant noncontrolling interest percentage in the Condensed Consolidated Statements of Operations.

### NINE MONTHS ENDED MARCH 31, 2020 AS COMPARED TO NINE MONTHS ENDED MARCH 31, 2019

NET REVENUES

In the nine months ended March 31, 2020, net revenues decreased 11%, or $717.3, to $5,815.8 from $6,533.1 in the nine months ended March 31, 2019. Excluding the impact of the Acquisition and the Divestiture, total net revenues decreased 9%, or $555.5, to $5,766.4 in the nine months ended March 31, 2020 from $6,321.9 in the nine months ended March 31, 2019, reflecting a negative foreign currency exchange translation impact of 2%, and a decrease in unit volume of 10%, partially offset by a positive price and mix impact of 3%. The decrease in net revenues primarily reflects lower net revenues due to the COVID-19 pandemic, impacting all product categories across the Company, with the highest impact on the prestige products, professional products, mass color cosmetics and retail hair, due to the closure of retail malls, professional salons, travel retail channels and certain mass channels. *Calvin Klein, Gucci, Hugo Boss, Burberry* and *Wella Professional* were prestige and professional brands with the highest net revenue decrease. The impact to the mass category brands sold in drug and grocery stores, although significant due to social distancing directives, was relatively mitigated due to these distribution channels mostly remaining open. The corresponding net revenue declines in the mass channel were mainly seen in *CoverGirl, Rimmel, Max Factor* and *Bourjois.*

### Net Revenues by Segment

*(in millions)*

| NET REVENUES | Nine Months Ended March 31, 2020 | 2019 | Change % |
| --- | ---: | ---: | ---: |
| Americas | $1,689.0 | $1,897.4 | (11)% |
| EMEA | 2,229.7 | 2,406.0 | (7)% |
| Asia Pacific | 537.5 | 606.5 | (11)% |
| Professional Beauty | 1,304.1 | 1,348.6 | (3)% |
| Other | 55.5 | 274.6 | (80)% |
| **Total** | **$5,815.8** | **$6,533.1** | **(11)%** |

#### Americas

In the nine months ended March 31, 2020, net revenues from the Americas segment decreased 11%, or $208.4, to $1,689.0 from $1,897.4 in the nine months ended March 31, 2019. Excluding the impact of the Acquisition, net revenues from the Americas segment decreased 13%, or $245.4, to $1,652.0 in the nine months ended March 31, 2020 from $1,897.4 in the nine months ended March 31, 2019, reflecting a decrease in unit volume of 14% and a negative foreign currency exchange translation impact of 2%, offset by a positive price and mix impact of 3%. The decrease in net revenues primarily reflects:

(i) lower net revenues due to the COVID-19 pandemic, impacting all product categories across the segment, with the highest impact on prestige products due to the closure of retail malls and travel retail channels. *Calvin Klein, philosophy, Gucci, Burberry* and *Marc Jacobs* were prestige brands with the highest net revenue decrease. The impact to the mass category brands sold in drug and grocery stores, although significant due to social distancing directives, was relatively mitigated due to these distribution channels mostly remaining open. The corresponding net revenue declines in the mass channel were mainly seen in *CoverGirl* and *Rimmel;*

(ii) shelf-space losses in the United States primarily impacting *CoverGirl, Rimmel* and *philosophy* which have contributed to the negative share trends in the mass color cosmetics and prestige skin products;

(iii) negative category trends in the United States for mass color cosmetics and mass fragrances;

(iv) declines in *Calvin Klein* due to a reduced focus on lower margin products, including gift-sets, and lower launch activity in the current year; and

(v) declines in *Monange* and *Bozzano* in Brazil primarily driven by the negative impact of foreign currency exchange translation, partially offset by a strong improvement in price and mix.

These decreases were partially offset by:

(i) increased net revenues in the first half of fiscal 2020 due to the resolution of the supply chain disruptions which negatively impacted net revenues in the prior year;

(ii) incremental net revenues from *Tiffany & Co* due to the launch of *Tiffany & Love* in the prior quarter; and

(iii) increased net revenues from *Sally Hansen* due to continued success across its core sub-brands as well as incremental net revenues from the launch of *Sally Hansen Good.Kind.Pure.*

#### EMEA

In the nine months ended March 31, 2020, net revenues from the EMEA segment decreased 7%, or $176.3, to $2,229.7 from $2,406.0 in the nine months ended March 31, 2019, reflecting a decrease in unit volume of 8% and a negative foreign currency exchange translation impact of 2%, partially offset by a positive price and mix impact of 3%. The decrease in net revenues primarily reflects:

(i) lower net revenues in the third quarter due to the COVID-19 pandemic, impacting all product categories across the segment, primarily in Italy, Spain and the Middle East, with the highest impact on prestige products due to the closure of retail malls and travel retail channels. *Calvin Klein, Hugo Boss,* and *Gucci* were prestige brands with the highest net revenue decrease. These decreases more than offset the increased net revenues from prestige products in the first half of the fiscal year. The impact to the mass category brands sold in drug and grocery stores, although significant due to social distancing directives, was relatively mitigated due to these distribution channels mostly remaining open. The corresponding net revenue declines in the mass channel were mainly seen in *Bourjois, Rimmel* and the retail hair line of *Wella;*

(ii) declines in *adidas, Rimmel, Bourjois, Max Factor* and mass fragrances due to a renegotiation with key third party distributors in the Middle East and strategic distribution limits in Africa;

(iii) negative share trends in Europe for mass color cosmetics partially due to a strategic decision to withdraw *Bourjois* in the UK and negative share trends for hair color;

(iv) negative category trends in Europe for mass color cosmetics and hair color impacting *Bourjois* and the retail hair line of *Wella;*

(v) declines in *adidas* and the retail hair line of *Wella* due to geopolitical disruptions in the Middle East;

(vi) decreased e-commerce sales primarily in *Calvin Klein, Roberto Cavalli, Joop* and *Jil Sander*; and

(vii) declines from *Calvin Klein* and *Jil Sander* in Germany due to a reduced focus on lower margin products, including gift-sets.

These decreases were partially offset by:

(i) increased net revenues in the first half of fiscal 2020 due to the resolution of the supply chain disruptions which negatively impacted net revenues in the prior year;

(ii) incremental net revenues from *Burberry* in the first half of fiscal 2020 due to continued success from the launch of *Burberry Her* in the prior year;

(iii) incremental net revenues from *Lacoste* in Russia from the launch of *Lacoste Timeless* in the first quarter of fiscal 2020; and

(iv) increased net revenues from *Bruno Banani* mainly driven by the launch of *Bruno Banani Loyal Man* in Germany.

#### Asia Pacific

In the nine months ended March 31, 2020, net revenues from the Asia Pacific segment decreased 11%, or $69.0, to $537.5 from $606.5 in the nine months ended March 31, 2019, reflecting a decrease in unit volume of 13% and a negative foreign currency exchange translation impact of 2%, partially offset by a positive price and mix impact of 4%. The decrease in net revenues primarily reflects:

(i) lower net revenues due to the COVID-19 pandemic, impacting all product categories across the segment, primarily in China, with the highest impact on the prestige category due to the closure of retail malls and travel retail channels. *Gucci, Calvin Klein, Burberry* and *Miu Miu* were prestige brands with the highest net revenue decrease. The impact to the mass category brands sold in drug and grocery stores, although significant due to social distancing directives, was relatively mitigated due to these distribution channels mostly remaining open. The corresponding net revenue declines in the mass channel were mainly seen in *Max Factor* and *Rimmel;*

(ii) lower net revenues due to the Hong Kong protests, impacting mainly the prestige brands, primarily in China and the travel retail channel;

(iii) declines in *Max Factor* in China in an effort to optimize trade inventory levels; and

(iv) declines from strategic initiatives to reduce distribution through lower priced channels in Southeast Asia impacting brands across the mass fragrance category.

These decreases were partially offset by:

(i) increased net revenues from the relaunch of *Gucci Make-up* in the Asia Pacific travel retail channel, despite geopolitical disruptions in Hong Kong; and

(ii) increased net revenues in the first half of the fiscal 2020 due to the continued success from the launch of *Burberry Her* in the prior year.

#### Professional Beauty

In the nine months ended March 31, 2020, net revenues from the Professional Beauty segment decreased 3%, or $44.5, to $1,304.1 from $1,348.6 in the nine months ended March 31, 2019, reflecting a negative foreign currency exchange translation impact of 2%, and a decrease in unit volume of 5%, partially offset by a positive price and mix impact of 4%. The decrease in this segment primarily reflects lower net revenues due to the COVID-19 pandemic, with the highest impact on *Wella Professional* and *OPI*. These decreases were partially offset by:

(i) increased net revenues in the first half of fiscal 2020, mainly driven by the continued success of *ghd Glide* and *ghd Oracle*, as well as increased *ghd* e-commerce sales; and

(ii) increased net revenues in the first half of fiscal 2020 due to the resolution of the supply chain disruptions which negatively impacted nail professional products in the prior year.

#### Other

Other consists of the net revenues from the Divestiture of Younique.

COST OF SALES

In the nine months ended March 31, 2020, cost of sales decreased 12%, or $292.2, to $2,214.8 from $2,507.0 in the nine months ended March 31, 2019. Cost of sales as a percentage of net revenues decreased to 38.1% in the nine months ended March 31, 2020 from 38.4% in the nine months ended March 31, 2019 resulting in a gross margin increase of approximately 30 basis points primarily reflecting:

(i) a favorable mix impact associated with the increased proportion of net revenue contribution from higher-margin prestige and Professional Beauty products;

(ii) increased gross margin due to sales price increases for *Monange* and *Bozzano* in Brazil in the current period, compared to a lower base due to negative mix impact associated with a higher proportionate net revenue contribution from lower-margin body care products in the prior period;

(iii) reduced focus on lower margin products, including gift-sets, contributing to manufacturing efficiencies for prestige products; and

(iv) a decrease in excess and obsolescence expense on inventory in the Corporate segment for artwork transition activities on acquired inventory in connection to the acquisition of the P&G Beauty Business.

These improvements were partially offset by:

(i) incremental expense of underutilized facilities costs due to reduced sales volume resulting from the COVID-19 pandemic;

(ii) gross margin impacts from the Divestiture due to prior year margin benefits provided by Younique;

(iii) increased excess and obsolescence expense on inventory, primarily in prestige products, due to the COVID-19 pandemic; and

(iv) negative foreign currency exchange on imported materials, primarily impacting Brazil.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

In the nine months ended March 31, 2020, selling, general and administrative expenses decreased 6%, or $202.5, to $3,274.3 from $3,476.8 in the nine months ended March 31, 2019. Selling, general and administrative expenses as a percentage of net revenues increased to 56.3% in the nine months ended March 31, 2020 from 53.2% in the nine months ended March 31, 2019, or approximately 310 basis points. This increase was primarily due to:

(i) 120 basis points related to higher administrative costs as a percentage of net revenue as the compensation expense savings and from prior restructuring programs were out-paced by the decline in net revenues;

(ii) 50 basis points related to higher share-based compensation due to significant executive forfeitures of share-based compensation instruments in the prior year;

(iii) 40 basis points related to higher bad debt expense;

(iv) 30 basis points related to higher negative transactional impact from our exposure to foreign currency exchange fluctuations;

(v) 30 basis points related to higher advertising and consumer promotion costs as a percentage of net revenues as the savings in media and promotional trade spending from the COVID-19 pandemic were out-paced by the decline in net revenues; and

(vi) 40 basis points related to other expenses.

OPERATING INCOME (LOSS)

In the nine months ended March 31, 2020, operating loss was $97.4 compared to a loss of $739.8 in the nine months ended March 31, 2019. Operating margin, or operating loss as a percentage of net revenues, decreased to (1.7)% in the nine months ended March 31, 2020 as compared to (11.3)% in the nine months ended March 31, 2019. The operating margin improvements are largely driven by the asset impairment charges incurred in the prior year, partially offset by reduced net revenues due to the impact from the COVID-19 pandemic, and increased selling and general administrative expenses as a percentage of net revenues in the current year.

### Operating Income (Loss) by Segment

*(in millions)*

| Operating income (loss) | Nine Months Ended March 31, 2020 | 2019 | Change % |
| --- | ---: | ---: | ---: |
| Americas | $20.0 | $(293.3) | \>100% |
| EMEA | 108.8 | (207.6) | \>100% |
| Asia Pacific | 3.0 | (29.4) | \>100% |
| Professional Beauty | 112.4 | 110.8 | 1% |
| Other | (11.0) | (11.0) | —% |
| Corporate | (330.6) | (309.3) | (7)% |
| **Total** | **$(97.4)** | **$(739.8)** | **87%** |

#### Americas

In the nine months ended March 31, 2020, operating income for Americas increased \>100%, or $313.3, to $20.0 from $(293.3) in the nine months ended March 31, 2019. Operating margin increased to 1.2% of net revenues in the nine months ended March 31, 2020 as compared to (15.5)% in the nine months ended March 31, 2019, primarily reflecting the asset impairment charges in the prior year and lower cost of goods sold as a percentage of net revenues, partially offset by reduced net revenues due to the impact from the COVID-19 pandemic, higher selling, general, and administrative expense as a percentage of net revenues, and higher amortization as a percentage of net revenue.

#### EMEA

In the nine months ended March 31, 2020, operating income for EMEA increased \>100%, or $316.4, to $108.8 from $(207.6) in the nine months ended March 31, 2019. Operating margin increased to 4.9% of net revenues in the nine months ended March 31, 2020 as compared to (8.6)% in the nine months ended March 31, 2019, primarily reflecting the asset impairment charges in the prior year, partially offset by reduced net revenues due to the impact from the COVID-19 pandemic, higher selling, general, and administrative expense as a percentage of net revenues, higher cost of goods sold as a percentage of net revenues, and higher amortization as a percentage of net revenue.

#### Asia Pacific

In the nine months ended March 31, 2020, operating income for Asia Pacific increased \>100%, or $32.4, to $3.0 from $(29.4) in the nine months ended March 31, 2019. Operating margin increased to 0.6% of net revenues in the nine months ended March 31, 2020 as compared to (4.8)% in the nine months ended March 31, 2019, primarily reflecting the asset impairment charges in the prior year and lower cost of goods sold as a percentage of net revenues, partially offset by reduced net revenues due to the impact from the COVID-19 pandemic, higher selling, general and administrative expenses as a percentage of net revenues.

#### Professional Beauty

In the nine months ended March 31, 2020, operating income for Professional Beauty increased 1%, or $1.6, to $112.4 from $110.8 in the nine months ended March 31, 2019. Operating margin increased to 8.6% of net revenues in the nine months ended March 31, 2020 as compared to 8.2% in the nine months ended March 31, 2019, primarily driven by lower selling and general administrative costs as a percentage of net revenues and lower cost of goods sold as a percentage of net revenues.

#### Other

Other represents operating income (loss) from the Divestiture of Younique.

#### Corporate

Corporate primarily includes corporate expenses not directly related to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.

In the nine months ended March 31, 2020, the operating loss for Corporate was $330.6 compared to a loss of $309.3 in the nine months ended March 31, 2019, as described under “Adjusted Operating Income for Coty Inc.” below. The increase to operating loss for Corporate was primarily driven by an increase in restructuring and other business realignment costs, as well as an increase in acquisition and divestiture related costs, partially offset by a decrease in asset impairment charges and by the gain on sale of business.

### Adjusted Operating Income (Loss) by Segment

We believe that Adjusted Operating income (loss) by segment further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” A reconciliation of reported Operating income (loss) to Adjusted Operating income is presented below, by segment:

*(in millions)*

| Operating income (loss) | Nine Months Ended March 31, 2020 Reported (GAAP) | Adjustments (a) | Adjusted (Non-GAAP) |
| --- | ---: | ---: | ---: |
| Americas | 20.0 | $(66.8) | $86.8 |
| EMEA | 108.8 | (101.8) | 210.6 |
| Asia Pacific | 3.0 | (21.2) | 24.2 |
| Professional Beauty | 112.4 | (51.5) | 163.9 |
| Other | (11.0) | (7.4) | (3.6) |
| Corporate | (330.6) | (328.5) | (2.1) |
| **Total** | **$(97.4)** | **$(577.2)** | **$479.8** |

*(in millions)*

| Operating (loss) income | Nine Months Ended March 31, 2019 Reported (GAAP) | Adjustments (a) | Adjusted (Non-GAAP) |
| --- | ---: | ---: | ---: |
| Americas | (293.3) | $(472.3) | $179.0 |
| EMEA | (207.6) | (477.9) | 270.3 |
| Asia Pacific | (29.4) | (93.0) | 63.6 |
| Professional Beauty | 110.8 | (52.7) | 163.5 |
| Other | (11.0) | (26.1) | 15.1 |
| Corporate | (309.3) | (310.4) | 1.1 |
| **Total** | **$(739.8)** | **$(1,432.4)** | **$692.6** |

54

(a) See a reconciliation of reported operating income to adjusted operating income and a description of the adjustments under “Adjusted Operating Income for Coty Inc.” below. All adjustments are reflected in Corporate, except for amortization and asset impairment charges on goodwill, regional indefinite-lived intangible assets, and finite-lived intangible assets, which are reflected in the Americas, EMEA, Asia Pacific, Professional Beauty and Other segments.

### Adjusted Operating Income for Coty Inc.

We believe that adjusted operating income further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” A reconciliation of reported operating income (loss) to adjusted operating income is presented below:

*(in millions)*

|  | Nine Months Ended March 31, 2020 | 2019 | Change % |
| --- | ---: | ---: | ---: |
| **Reported operating income (loss)** | **$(97.4)** | **$(739.8)** | **87%** |
| % of net revenues | (1.7)% | (11.3)% |  |
| Asset impairment charges | 40.4 | 977.7 | (96)% |
| Restructuring and other business realignment costs | 287.3 | 187.0 | 54% |
| Amortization expense | 248.7 | 267.7 | (7)% |
| Acquisition and divestiture-related costs | 85.3 | — | N/A |
| (Gain)/Loss on sale of business | (84.5) | — | N/A |
| Total adjustments to reported operating income | $577.2 | $1,432.4 | (60)% |
| **Adjusted operating income** | **$479.8** | **$692.6** | **(31)%** |
| % of net revenues | 8.2% | 10.6% |  |

Adjusted operating income in the nine months ended March 31, 2020 decreased 31%, or $212.8, to $479.8 from $692.6 in the nine months ended March 31, 2019. Adjusted operating margin decreased to 8.2% of net revenues in the nine months ended March 31, 2020 as compared to 10.6% in the nine months ended March 31, 2019, primarily driven by reduced net revenues due to the COVID-19 pandemic, higher selling, general and administrative costs as a percentage of net revenues and higher cost of goods sold as a percentage of net revenues. Excluding the impact of foreign currency exchange translations, adjusted operating income decreased 28%.

#### Asset Impairment Charges

In the nine months ended March 31, 2020, we incurred asset impairment charges of $40.4 in Corporate, relating to indefinite-lived other intangible assets (related to the *CoverGirl, Max Factor* and *Bourjois* trademarks).

In the nine months ended March 31, 2019, we incurred $977.7 of asset impairment charges primarily due to $930.3 related to goodwill and other intangible assets in the Americas, EMEA and Asia Pacific segments recorded during the second quarter; $22.8 related to the *philosophy* trademark recorded during the second quarter; $12.6 charge during the first quarter due to an acquired trademark associated with a terminated pre-existing license as a result of the acquisition; and $12.0 related to a Corporate equity security investment recorded during the second quarter.

#### Amortization Expense

In the nine months ended March 31, 2020, amortization expense decreased to $248.7 from $267.7 in the nine months ended March 31, 2019. In the nine months ended March 31, 2020, amortization expense of $66.8, $101.8, $21.2, $51.5 and $7.4 was reported in the Americas, EMEA, Asia Pacific, Professional Beauty, and Other segments, respectively. In the nine months ended March 31, 2019, amortization expense of $61.8, $106.2, $20.9, $52.7, and $26.1 was reported in the Americas, EMEA, Asia Pacific, Professional Beauty, and Other segments, respectively.

#### Restructuring and Other Business Realignment Costs

We continue to analyze our cost structure, including opportunities to simplify and optimize operations. On July 1, 2019, we announced our Turnaround Plan. To implement the Turnaround Plan, we expect to incur restructuring and other business realignment costs, in addition to costs associated with previously announced programs. The Company expects incremental cash costs related to the Turnaround Plan to be approximately $600.0. In addition, the Company will continue to incur cash costs of $160.0 related to restructuring and other business realignment costs connected to previously announced programs. During the nine months ended March 31, 2020 we spent approximately $162.0 in connection with the execution of the Turnaround Plan and our previously announced programs.

Prior to July 1, 2019, we incurred restructuring and related costs aimed at integrating and optimizing the combined organization following the acquisition of the P&G Beauty Business, which we refer to as the Global Integration Activities, and reducing fixed costs and enabling further investment in the business, which we refer to as the 2018 Restructuring Actions.

In the nine months ended March 31, 2020, we incurred restructuring and other business structure realignment costs of $287.3, as follows:

- We incurred restructuring costs of $134.2 primarily related to the Turnaround Plan, included in the Condensed Consolidated Statements of Operations.
- We incurred business structure realignment costs of $153.1 primarily related to our Turnaround plan and certain other programs. This amount includes $141.9 reported in selling, general and administrative expenses, primarily related to severance, consulting costs and accelerated depreciation costs; and $11.2 reported in cost of sales in the Condensed Consolidated Statement of Operations.

In the nine months ended March 31, 2019, we incurred restructuring and other business structure realignment costs of $187.0 as follows:

- We incurred Restructuring costs of $43.7 primarily related to the Global Integration Activities and 2018 Restructuring Actions, included in the Condensed Consolidated Statements of Operations.
- We incurred business structure realignment costs of $143.3 primarily related to our Global Integration Activities and certain other programs. Of this amount $131.3 is included in selling, general and administrative expenses and $12.0 is included in cost of sales, primarily due to costs incurred for the realignment of the business due to the P&G Beauty Business.

In all reported periods, all restructuring and other business realignment costs were reported in Corporate.

#### Acquisition and Divestiture Activities

In the nine months ended March 31, 2020, we incurred $85.3 of cost relating to consulting and legal fees associated with the King Kylie Transaction, as well as consulting and legal fees associated with the process to explore strategic alternatives, including divestment, for the Professional Beauty business including associated hair brands sold by the Americas, EMEA and Asia Pacific segments, as well as our Brazilian operations.

In the nine months ended March 31, 2019, there were no acquisition or divestiture-related charges incurred.

In all reported periods, all costs related to acquisition and divestiture activities were reported in Corporate.

#### Gain (Loss) on Sale of Business

In the nine months ended March 31, 2020, we completed the divestiture of Younique resulting in income of $84.5 included in Gain on sale of business in the Condensed Consolidated Statements of Operations. In the nine months ended March 31, 2019, we did not divest any business.

INTEREST EXPENSE, NET

In the nine months ended March 31, 2020, net interest expense was $222.1 as compared with $204.4 in the nine months ended March 31, 2019. This increase is primarily due to the impact of transactional foreign exchange.

INCOME TAXES

The effective income tax rate for the nine months ended March 31, 2020 and 2019 was 30.6% and (0.1)%, respectively. The positive effective tax rate in the nine months ended March 31, 2020 results from reporting losses before taxes and a benefit for income taxes. The negative effective tax rate in the nine months ended March 31, 2019 results from reporting losses before income taxes and a provision for income taxes. The change in the effective tax rate for the nine months ended March 31, 2020, as compared to the prior period is primarily due to goodwill impairment recorded in the prior period that was not tax deductible.

The effective income tax rates vary from the blended rate of approximately 21% due to the effect of: (i) jurisdictions with different statutory rates, (ii) adjustments to our unrecognized tax benefits and accrued interest; (iii) non-deductible expenses, (iv) audit settlements and (v) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.

On March 27, 2020, the United States government passed the CARES Act. The Company has analyzed the provisions, which include modifications to net operating loss limitations, modifications to the deductibility of business interest expense, as well as AMT credit acceleration, and interim reporting considerations and there is no impact to the current period.

### Reconciliation of Reported (Loss) Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:

*(in millions)*

|  | Nine Months Ended March 31, 2020 (Loss) Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate | Nine Months Ended March 31, 2019 (Loss) Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| **Reported (loss) income before income taxes** | **$(323.5)** | **$(99.0)** | **30.6%** | **$(969.2)** | **$0.9** | **(0.1)%** |
| Gain on sale of business adjustment (a)(b) | (84.5) | 4.8 |  |  |  |  |
| Other adjustments to reported operating income (a)(b) | 661.7 | 138.1 |  | 1,432.4 | 84.5 |  |
| Other adjustments (b)(c) | $— | $— |  | 12.7 | 0.8 |  |
| **Adjusted income before income taxes** | **$253.7** | **$43.9** | **17.3%** | **$475.9** | **$86.2** | **18.1%** |

(a) See a description of adjustments under “Adjusted Operating Income for Coty Inc.”

(b) The tax effects of each of the items included in adjusted income are calculated in a manner that results in a corresponding income tax expense/provision for adjusted income. In preparing the calculation, each adjustment to reported income is first analyzed to determine if the adjustment has an income tax consequence. The provision for taxes is then calculated based on the jurisdiction in which the adjusted items are incurred, multiplied by the respective statutory rates and offset by the increase or reversal of any valuation allowances commensurate with the non-GAAP measure of profitability.

(c) In the three months ended March 31, 2019, the Company incurred legal and advisory services of $12.7 rendered in connection with the evaluation of the tender offer initiated by certain of our shareholders.

The adjusted effective tax rate was 17.3% for the nine months ended March 31, 2020 compared to 18.1% for the nine months ended March 31, 2019. The differences were primarily due to the jurisdictional mix of income.

NET INCOME (LOSS) ATTRIBUTABLE TO COTY INC.

Net income (loss) attributable to Coty Inc. was a loss of $240.4 in the nine months ended March 31, 2020, as compared to a loss of $984.8 in the nine months ended March 31, 2019. This decrease primarily reflects the divestiture of Younique resulting in $84.5 of income reflected in Gain on sale of business in the Condensed Consolidated Statements of Operations for the nine months ended March 31, 2020 and asset impairment charges of $977.7 recorded in the prior period.

We believe that adjusted net income attributable to Coty Inc. provides an enhanced understanding of our performance. See “Overview—Non-GAAP Financial Measures.”

*(in millions)*

|  | Nine Months Ended March 31, 2020 | 2019 | Change % |
| --- | ---: | ---: | ---: |
| **Reported net income (loss) attributable to Coty Inc.** | **$(240.4)** | **$(984.8)** | **76%** |
| % of net revenues | (4.1)% | (15.1)% |  |
| Adjustments to reported operating income (a) | 577.2 | 1,432.4 | (60)% |
| Adjustments to other expense(b) | — | 12.7 | (100)% |
| Adjustments to noncontrolling interests (b) | 0.1 | (11.0) | \>100% |
| Change in tax provision due to adjustments to reported net income attributable to Coty Inc. | (142.9) | (85.3) | (68)% |
| **Adjusted net income attributable to Coty Inc.** | **194.0** | **364.0** | **(47)%** |
| % of net revenues | 3.3% | 5.6% |  |
| **Per Share Data** |  |  |  |
| Adjusted weighted-average common shares |  |  |  |
| Basic | 757.7 | 751.1 |  |
| Diluted | 762.1 | 753.0 |  |
| Adjusted net income attributable to Coty Inc. per common share |  |  |  |
| Basic | $0.26 | $0.48 |  |
| Diluted | 0.25 | 0.48 |  |

(a) See a description of adjustments under “Adjusted Operating Income for Coty Inc.”

(b) The amounts represent the after-tax impact of the non-GAAP adjustments included in Net income attributable to noncontrolling interest based on the relevant noncontrolling interest percentage in the Condensed Consolidated Statements of Operations.

### FINANCIAL CONDITION

LIQUIDITY AND CAPITAL RESOURCES

### Overview

Our primary sources of funds include cash expected to be generated from operations, borrowings from issuance of debt and committed and uncommitted lines of credit provided by banks and lenders in the U.S. and abroad.

Our cash flows are subject to seasonal variation throughout the year, including demands on cash made during the three and six months buildup before the holiday season in anticipation of higher global sales during the second fiscal quarter. In the second fiscal quarter, we typically experience strong cash generation as a result of increased demand by retailers associated with the holiday season. In the third quarter, we experience cash demands immediately following the holiday season, primarily related to post-holiday sales returns and annual bonus payments to the retailers, as well as higher vendor payments related to certain products and services incurred for the holiday season.

Our principal uses of cash are to fund operating expenditures, capital expenditures, business structure realignment expenditures, interest payments, acquisitions, dividends, share repurchases and any principal payments on debt. Working capital movements are influenced by the sourcing of materials related to the production of products. Cash and working capital management initiatives, including the phasing of vendor payments and factoring of trade receivables from time-to-time, may also impact the timing and amount of our operating cash flows. In addition, cash generated from the divestiture of any businesses during the next year will be utilized to reduce debt, other than a maximum of $500.0 that will be used to fund operations.

#### Our response to the impact of COVID-19

In response to the risks presented by the COVID-19 pandemic, we have been actively implementing a number of measures to bolster our liquidity position and provide additional financial flexibility. Such measures include actively aligning operating expenses to the current state of the business, including slowing down our production to adjust our inventories, the recently announced temporary compensation reductions for certain executives and for our non-executive board members, hiring and travel restrictions, temporary furloughs for certain employees and the reduction of advertising and consumer promotion costs for sales channels that are closed or heavily impacted by social distancing. We intend to utilize any tax payment deferrals that apply to us in specific jurisdictions. We will actively manage our working capital to support our liquidity needs. Additionally, we announced on May 11, 2020, that KKR will be purchasing $750.0 of convertible preferred stock in Coty, which provides us with additional liquidity. See additional information in Note 19—Subsequent Events.

Due in part to these measures, our current cash position is favorable; as of March 31, 2020, we had cash and cash equivalents of $1,278.5 compared with $340.4 as of June 30, 2019. As of March 31, 2020, we had $1,289.7 of immediate liquidity, which consisted of available cash and cash equivalents and available borrowings under our 2018 Coty Revolving Credit Facility.

While the impact and duration of COVID-19 on our business is currently uncertain, as a result of the cash on hand, our amended debt covenants, our plans to manage expenses and the cash we expect to receive from KKR from the issuance of convertible preferred stock, we believe we have sufficient liquidity and covenant headroom to meet our foreseeable business operating and recurring cash needs (including for debt service and capital expenditures). To address the potentially longer-lasting impacts of the COVID-19, the lockdown and a possible recession resulting from COVID-19 in many markets, we will be implementing a plan to reduce our cost base, which does not vary with revenues, by 25%, including an adaptation of our supply network and organization as well as a reduction of certain discretionary expenses.

### Debt

See Note 10—Debt in the notes to our Condensed Consolidated Financial Statements for additional information on our debt arrangements and prior period credit agreements.

Based on our credit agreement (the “2018 Coty Credit Agreement”), as amended, the calculation of our financial covenant for net debt excludes the impact of operating leases, and thus, the adoption of the new leasing standard, ASU 2016-02, *Leases* (Topic 842), (see Note 2—Summary of Significant Accounting Policies), did not impact our financial covenants. In order to be consistent with our financial covenant, we will continue to report our net debt calculation excluding operating leases.

On April 29, 2020, we amended our existing credit agreement. The amendment (i) provides a Total Net Leverage Ratio financial covenant “holiday” through March 31, 2021; (ii) establishes a minimum liquidity covenant through March 31, 2021 of $350 million; and (iii) effectively places certain limitations on the ability to make certain investments and restricted payments (including limiting our ability to pay dividends in cash through March 31, 2021) and on incurring additional indebtedness. The amendment does not modify the applicable funding costs during the period through March 31, 2021.

### Factoring of Receivables

From time to time, we supplement the timing of our cash flows through the factoring of trade receivables. In this regard, we have entered into factoring arrangements with financial institutions. Most recently, these agreements included the following:

#### U.S. Receivables Purchase Agreement

In March of fiscal 2019, we entered into a receivables purchase agreement with a financial institution, with an aggregate facility limit of $150.0 to facilitate factoring of receivables by certain of our U.S. subsidiaries (the “U.S. Receivables Purchase Agreement”). Factoring of such receivables under the U.S. Receivables Purchase Agreement may be executed on a recourse or non-recourse basis.

During the nine months ended March 31, 2020, total cash received for trade receivables factored under the U.S. Receivables Purchase Agreement, net of collections and factoring costs, was $(15.8). Gross trade receivables factored under the U.S. Receivables Purchase Agreement during the nine months ended March 31, 2020 totaled $394.0. Remaining balances due from the factor amounted to $2.1, as of March 31, 2020.

#### European Receivables Purchase Agreement

In September of fiscal 2020, we entered into a factoring agreement with a financial institution, which allows for the transfer of receivables from certain of our European subsidiaries, in exchange for cash (the “European Receivables Purchase Agreement”). The total outstanding amount permitted among such subsidiaries is €93.0 million. Factoring of such receivables under the European Receivables Purchase Agreement is executed on a non-recourse basis.

During the nine months ended March 31, 2020, total cash received for trade receivables factored under the European Receivables Purchase Agreement, net of collections and factoring costs, was $36.7. Gross trade receivables factored under the European Receivables Purchase Agreement during the nine months ended March 31, 2020 totaled $282.6. Remaining balances due from the factor amounted to $6.4, as of March 31, 2020.

### Cash Flows

| Condensed Consolidated Statements of Cash Flows Data: (in millions) | Nine Months Ended March 31, 2020 | 2019 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $204.5 | $451.4 |
| Net cash used in investing activities | (772.8) | (371.0) |
| Net cash provided by (used in) financing activities | 1,529.8 | (16.7) |

#### Net cash provided by operating activities

Net cash provided by operating activities was $204.5 and $451.4 for the nine months ended March 31, 2020 and 2019, respectively, a decrease of $246.9. Operating cash inflows were impacted by a decrease of $267.3 in cash related to net income period over period, positively impacted by net changes in working capital accounts of $62.4 and negatively impacted by higher outflows related to noncurrent assets and liabilities of $42.0. Higher inflows from working capital in the current period are primarily a result of lower cash outflows from accrued expenses and other current liabilities, which were primarily the result of lower payments for restructuring and business realignment programs in the current period. Furthermore, changes in inventories contributed of the increase due to improved inventory management and the reversal of the prior period impact of the supply chain disruptions. Partially offsetting were lower inflows related to accounts receivables to lower incremental benefit from factoring and higher outflows due to accounts payables due to lower spending and a change in the timing of payments compared to the prior period.

#### Net cash used in investing activities

Net cash used in investing activities was $772.8 and $371.0 for the nine months ended March 31, 2020 and 2019, respectively. The increase in net cash used in investing activities of $401.8 was primarily driven by the payment, net of cash acquired of $592.2 for the purchase of 51% of the equity interest of King Kylie, LLC compared to $40.8 of cash used for the purchase of a trademark in the prior year which did not reoccur in the current year. The overall increase in cash used in investing activities was partially offset by lower capital expenditures of $124.5 during the comparative nine months ended March 31, 2020 and 2019 and $25.6 of net cash proceeds from the sale of the Younique business during the first quarter of fiscal 2020.

#### Net cash provided by (used in) financing activities

Net cash provided by financing activities during the nine months ended March 31, 2020 was $1,529.8 compared to net cash used in financing activities of $16.7 during the nine months ended March 31, 2019. The increase in cash from financing activities of $1,546.5 was primarily due to higher net proceeds associated with the Company's revolving loan facility during the nine months ended March 31, 2020 compared to net proceeds from revolver borrowings on this facility during the nine months ended March 31, 2019. The higher borrowings during the current year of $1,474.3 were primarily driven by the Company's response to the risks presented by the COVID-19 pandemic and the number of key financial measures taken which included fully drawing down on the Company's revolving loan facilities to ensure liquidity and cash availability. These borrowings are held as part of cash and cash equivalents as of March 31, 2020. In addition, at the beginning of this fiscal quarter, the Company used borrowings for its acquisition of 51% equity interest in King Kylie, LLC. for $600.0. The Company's Stock Dividend Reinvestment Program, which became available to stockholders in the fourth quarter of fiscal 2019, also had a positive impact on the cash from financing activities compared to the prior year as cash outflows for dividend payments were lower by $85.9 in the current year. To partially offset the increase in cash from financing activities, the Company paid $45.0 during the first quarter of fiscal 2020 to purchase the remaining mandatorily redeemable noncontrolling interest in the Company's Southeast Asian subsidiary, which did not occur in the prior year.

### Dividends

Our Board of Directors has suspended the payment of dividends, in keeping with our 2018 Coty Credit Agreement, as amended. As we focus on preserving cash, we expect to suspend the payment of dividends through April 1, 2021 or until such later date that we reach a Net debt to Adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”) of 4x. Any determination to pay dividends in the future will be at the discretion of our Board of Directors.

### Treasury Stock - Share Repurchase Program

For additional information on our Share Repurchase Program, see Note 14—Equity in the notes to our Condensed Consolidated Financial Statements.

### Commitments and Contingencies

### Mandatorily Redeemable Financial Interest

#### United Arab Emirates subsidiary

We are required under a shareholders agreement (the “U.A.E. Shareholders Agreement”) to purchase all of the shares held by the noncontrolling interest holder equal to 25% of a certain subsidiary in the United Arab Emirates (the “U.A.E. subsidiary”) at the termination of the agreement. We have determined such shares to be an MRFI that is recorded as a liability. The liability is calculated based upon a pre-determined formula in accordance with the U.A.E Shareholders Agreement. As of March 31, 2020 and June 30, 2019, the liability amounted to $9.4 and $7.5, of which $7.6 and $6.1, respectively, was recorded in Other noncurrent liabilities and $1.8 and $1.4, respectively, was recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheet.

#### Southeast Asian subsidiary

In July 2019, we purchased the remaining 49% noncontrolling interest of a certain Southeast Asian subsidiary from the noncontrolling interest holder for $45.0, pursuant to a Sale of Shares and Termination Deed, as amended. The termination was effective on June 30, 2019 and immediately prior to the cash purchase of the remaining noncontrolling interest, the noncontrolling interest balance was recorded as a MRFI liability. As of March 31, 2020, the remaining MRFI liability was nil.

### Redeemable Noncontrolling Interests

Noncontrolling interests, where we may be required to repurchase the noncontrolling interest under a put option or other contractual redemption requirement, are reported in the Condensed Consolidated Balance Sheet between liabilities and equity, as redeemable noncontrolling interests (“RNCI”). We adjust the RNCI to the higher of the redemption value or the carrying value (the acquisition date fair value adjusted for the noncontrolling interest’s share of net income (loss) and dividends) on each balance sheet date with changes recognized as an adjustment to additional paid-in capital (“APIC”).

#### Younique

On September 16, 2019, we completed the sale of all our membership interest in Foundation which held the net assets of Younique. On the date of this transaction, the Younique membership holders had a 40.7% membership interest in Foundation. See Note 5—Business Combinations, Asset Acquisitions and Divestitures. As a result of the sale of our membership interest in Foundation, RNCI of $360.4 was derecognized as of the date of sale.

We accounted for the 40.7% noncontrolling interest portion of Foundation as redeemable noncontrolling interest (“RNCI”) due to the noncontrolling interest holder’s right to put their shares to us in certain circumstances. Foundation was a majority-owned consolidated subsidiary through September 16, 2019 and we recorded income tax expense based on our 59.3% membership interest in Foundation due to its treatment as a partnership for U.S. income tax purposes. Accordingly, Foundation’s net income attributable to RNCI is equal to the 40.7% noncontrolling interest of Foundation’s net income excluding a provision for income taxes. We recognized $365.3 as the RNCI balance as of June 30, 2019.

#### Subsidiary in the Middle East

As of March 31, 2020, the noncontrolling interest holder in our subsidiary in the Middle East (“Middle East Subsidiary”) had a 25% ownership share. We recognized $98.6 and $86.5 as the RNCI balances as of March 31, 2020 and June 30, 2019, respectively.

### Legal Contingencies

#### Brazilian Tax Assessments

In connection with a local tax audit of one of our subsidiaries in Brazil, we were notified of tax assessments issued in March of 2018. The assessments relate to local sales tax credits, which the Treasury Office of the State of Goiás considers improperly registered for the 2016-2017 tax periods. We are currently seeking a favorable administrative decision on the tax enforcement action filed by the Treasury Office of the State of Goiás. These tax assessments, including estimated interest and penalties amount to a total of R$249.0 million (approximately $47.9). We believe we have meritorious defenses and we have not recognized a loss for these assessments as we do not believe a loss is probable.

### Off-Balance Sheet Arrangements

We had undrawn letters of credit of $5.0 and $6.3 and bank guarantees of $51.1 and $97.1 as of March 31, 2020 and June 30, 2019, respectively.

### Contractual Obligations

Our principal contractual obligations and commitments as of March 31, 2020 are summarized in Item 7 - “Management's Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources - Contractual Obligations and Commitments,” of our Fiscal 2019 Form 10-K, except as noted above. For the nine months ended March 31, 2020, there have been no material changes in our contractual obligations outside the ordinary course of business.

### Critical Accounting Policies

We believe that the critical accounting policies listed below involve our more significant judgments, assumptions and estimates and, therefore, could have the greatest potential impact on our Condensed Consolidated Financial Statements:

- Revenue Recognition;
- Goodwill, Other Intangible Assets and Long-Lived Assets;
- Business Combinations;
- Inventory; and
- Income Taxes.

As part of our quarterly review of the critical accounting policies during the first quarter of fiscal 2020, we concluded that the assumptions around Pension Benefit Costs and Redeemable Noncontrolling Interests no longer involved significant judgments, assumptions or estimates due to changes in our business, and thus excluded these policies from the above list. Below are updated disclosures regarding our goodwill and intangible assets. As of March 31, 2020, there have been no other material changes to the items disclosed as critical accounting policies and estimates in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in Part II—Item 7 of our Fiscal 2019 Form 10-K.

### Goodwill

#### Approach

Testing goodwill for impairment requires us to estimate fair values of reporting units using significant estimates and assumptions. The assumptions made will impact the outcome and ultimate results of the testing. We use industry accepted valuation models and set criteria that are reviewed and approved by various levels of management and, in certain instances, we engage independent third-party valuation specialists for advice. To determine fair value of the reporting unit, we used a combination of the income and market approaches. We believe the blended use of both models compensates for the inherent risk associated with either model if used on a stand-alone basis, and this combination is indicative of the factors a market participant would consider when performing a similar valuation.

Under the income approach, we determine fair value using a discounted cash flow method, projecting future cash flows of each reporting unit, as well as a terminal value, and discounting such cash flows at a rate of return that reflects the relative risk of the cash flows. Under the market approach, we utilize information from comparable publicly traded companies with similar operating and investment characteristics as the reporting units, which creates valuation multiples that are applied to the operating performance of the reporting units being tested, to value the reporting unit.

The key estimates and factors used in these approaches include revenue growth rates and profit margins based on our internal forecasts, our specific weighted-average cost of capital used to discount future cash flows, and comparable market multiples for the industry segment as well as our historical operating trends. Certain future events and circumstances, including deterioration of market conditions, higher cost of capital, a decline in actual and expected consumer consumption and demands, could result in changes to these assumptions and judgments. A revision of these assumptions could cause the fair values of the reporting units to fall below their respective carrying values. We would calculate an impairment charge as the difference between the reporting unit’s carrying value and fair value. Such charge could have a material effect on the Consolidated Statements of Operations and Balance Sheets.

#### Results

During the third quarter of fiscal 2020, the Company was adversely impacted by the COVID-19 global pandemic. This drove a decrease in net revenue, impacting all product categories across the Company, due to the closure of retail malls, professional salons, travel retail channels and certain mass channels. In response to these adverse business indicators and the rapidly declining revenue trends experienced during the third quarter of our 2020 fiscal year, we reduced our near-term revenue projection. As a result, we determined that our goodwill should be tested for potential impairment.

We performed an analysis of goodwill for impairment. The Company estimated the fair values of its reporting units based on discounted cash flow methodology reflecting the latest projections which included, among other things, the impact of COVID-19 pandemic for the Company’s impairment testing performed during the third quarter of our 2020 fiscal year. These projections assumed a gradual recovery from the COVID-19 pandemic beginning late in the fourth quarter of fiscal 2020 through the third quarter of fiscal 2021, which returns to normal business conditions prior to COVID-19. As such, the projected comparable growth rates in late fiscal 2021 and fiscal 2022 appear larger than previous and future years as they reflect the mechanical increases of the return to normal business conditions in the third quarter of fiscal 2021.

The fair values of each of the reporting units exceeded the respective carrying values of the reporting units as of March 31, 2020. Consequently, there were no goodwill impairment charges recorded as a result of the impairment testing performed during the third quarter of our 2020 fiscal year. During the third quarter impairment testing, all of the Company’s reporting units, with the exception of Americas and EMEA, fair value exceeded their respective carrying value by more than 20%. We determined that the fair values of the Americas and EMEA reporting units exceeded their carrying values by 15.9% and 4.4%, respectively, and had goodwill balances of $1,380.2 and $1,903.9, respectively. To determine the fair value of these reporting units, we have used an average annual revenue growth rate of 3.5% and 2.2% for fiscal 2021 to fiscal 2025, for Americas and EMEA, respectively, and a discount rate of 8.0%. The fair value of the Americas and EMEA reporting units would fall below their carrying values if the assumed average annual growth rate for fiscal 2021 to fiscal 2025 fell 144 and 53 basis points, respectively, or the discount rate increased by 87 and 25 basis points, respectively.

### Other Intangible Assets

The carrying value of our indefinite-lived other intangible assets was $2,667.3 as of March 31, 2020, and is comprised of trademarks for the following brands: CoverGirl of $474.5, the professional product line of Wella of $413.0, Max Factor of $237.8, Bourjois of $60.3, and other brands totaling $1,481.7.

#### Approach

The trademarks’ fair values are based upon the income approach, primarily utilizing the relief from royalty methodology. This methodology assumes that, in lieu of ownership, a third party would be willing to pay a royalty in order to obtain the rights to use the comparable asset. An impairment loss is recognized when the estimated fair value of the intangible asset is less than the carrying value. Fair value calculation requires significant judgments in determining both the assets’ estimated cash flows as well as the appropriate discount and royalty rates applied to those cash flows to determine fair value. Variations in the economic conditions or a change in general consumer demands, operating results estimates or the application of alternative assumptions could produce significantly different results.

#### Results

As noted above, during the third quarter of fiscal 2020, the Company was adversely impacted by the COVID-19 global pandemic. This drove a decrease in net revenue, impacting all product categories across the Company. As a result, we determined that our indefinite-lived intangible assets should be tested for potential impairment.

As a result of the lower revenue projections, the interim impairment test of indefinite-lived intangible assets resulted in the carrying values of certain tradenames and trademarks exceeding their estimated fair values. Accordingly, we recorded an impairment charge of $40.4 for the three and nine months ended March 31, 2020 to reflect such intangible assets at their estimated fair values. These impairments related to the CoverGirl ($26.5), Max Factor ($9.2) and Bourjois ($4.7) trademarks. The remaining carrying value of tradenames was approximately $2,667.3 as of March 31, 2020.

The fair value of the CoverGirl trademark fell below its carrying value using projections that assumed an average annual growth rate of 4.0% for fiscal 2021 to fiscal 2025, and a discount rate of 8.5%. The fair value of the Max Factor trademark fell below its carrying value using projections that assumed an average annual growth rate of 2.3% for fiscal 2021 to fiscal 2025, and a discount rate of 8.5%. The fair value of Bourjois trademark fell below its carrying value using projections that assumed an annual growth rate of (4.7%) for fiscal 2021 to fiscal 2025, and a discount rate of 8.5%.

As the trademarks for which impairment charges were recorded in the three and nine months ended March 31, 2020 no longer have any excess of their fair values over their carrying values, any material decline in assumed average annual revenue growth rates or increase in the discount rate could result in additional impairment charges.

As a result of the interim impairment test performed during the third quarter of fiscal 2020, we determined the fair value of our professional product line of Wella trademark exceeded its carrying value by less than 10% using projections that assumed an average annual revenue growth rate of 5.7% for fiscal 2021 to fiscal 2025, and a discount rate of 8.5%. The most significant assumptions used in this assessment were the revenue growth rate and discount rate.

Some of the inherent estimates and assumptions used in determining fair value of the reporting units are outside the control of management, including interest rates, cost of capital, tax rates, credit ratings and industry growth. Given the current COVID-19 global pandemic and the uncertainties regarding the financial potential impact on the Company's business, there can be no assurance that the Company's estimates and assumptions regarding the impact of COVID-19 and the recovery period made for purposes of the goodwill and indefinite-lived intangible asset interim impairment testing performed during the third quarter of our 2020 fiscal year will prove to be accurate predictions of the future. While the Company believes it has made reasonable estimates and assumptions to calculate the fair values of the reporting units and other indefinite-lived intangible assets, it is possible changes could occur. As for all the Company’s reporting units, if in future years, the reporting unit’s actual results are not consistent with the Company’s estimates and assumptions used to calculate fair value, the Company may be required to recognize material impairments to goodwill and/or indefinite-lived intangible assets. Regarding the indefinite-lived intangible assets, the most significant assumptions used are the revenue growth rate and the discount rate, a decrease in the revenue growth rate or an increase in the discount rate could result in a future impairment. The Company will continue to monitor its reporting units and indefinite-lived tradenames for any triggering events or other signs of impairment. The Company may be required to perform additional impairment testing based on changes in the economic environment, disruptions to the Company’s business, significant declines in operating results of the Company’s reporting units and/or tradenames, further sustained deterioration of the Company’s market capitalization, and other factors, which could result in impairment charges in the future. Although management cannot predict when improvements in macroeconomic conditions will occur, if consumer confidence and consumer spending decline significantly in the future or if commercial and industrial economic activity or the market capitalization deteriorates significantly from current levels, it is reasonably likely the Company will be required to record impairment charges in the future.

## Market risk

As filed, 181 characters.

There have been no material changes in market risk from the information provided in Item 7A. Quantitative and Qualitative Disclosures About Market Risk of our Fiscal 2019 Form 10-K.

## Controls and procedures

As filed, 3,527 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Our management, with the participation of our Chief Executive Officer (the “CEO”) and our Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2020. Based on the evaluation of our disclosure controls and procedures as of March 31, 2020, our CEO and CFO concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

### Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(f) of the Exchange Act during the third fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

### Inherent Limitations on Effectiveness of Controls

Our management, including our CEO and CFO, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving our objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

## Risk factors

As filed, 4,598 characters.

We have disclosed information about the risk factors that could adversely affect our business in Part I, Item 1A under the heading “Risk Factors” in our Annual Report on Form 10-K for fiscal 2019 and subsequent Quarterly Reports on Form 10-Q. The information presented below supplements and updates and should be read in conjunction with the risk factors and information disclosed in those periodic reports.

***Our operations and sales have been adversely impacted by the COVID-19 pandemic, and we must successfully manage the demand, supply, operational and financial challenges associated with the actual or perceived effects of COVID-19 and the related widespread public health crisis..***

Our business has been, and may continue to be, negatively impacted by the fear of exposure to or actual effects of the COVID-19 pandemic in countries where we operate or our customers are located, such as reduced travel or recommendations or mandates from governmental authorities to avoid large gatherings or to self-quarantine, as well as temporary closures of our facilities or the facilities of our customers or suppliers. These impacts include, but are not limited to:

- Significant reductions in demand or significant volatility in demand for one or more of our products, which may be caused by, among other things: the temporary inability of consumers to purchase our products due to illness, quarantine or other travel restrictions, store closures, or financial hardship, shifts in demand away from one or more of our more discretionary or higher priced products to lower priced products, or stockpiling or similar activity, supply chain and shipping constraints, reduced options for marketing and promotion of products or other restrictions in connection with COVID-19; if prolonged, such impacts can further increase the difficulty of operating our business, including accurately planning and forecasting, planning for operations and may adversely impact our results;
- Inability to meet our customers’ needs and achieve costs targets due to disruptions in our manufacturing and supply arrangements caused by the loss or disruption of essential manufacturing and supply elements such as raw materials or other finished product components, transportation, workforce, or other manufacturing and distribution capability, or the allocation of manufacturing capacity towards medical supplies such as hydro-alcoholic gel (which is used as hand sanitizer);
- Failure of third parties on which we rely, including our suppliers, our customers, contract manufacturers, distributors, contractors, commercial banks, joint venture partners and external business partners, to meet their obligations to the Company or to timely meet those obligations, or significant disruptions in their ability to do so, which may be caused by their own financial or operational difficulties and may adversely impact our operations; or
- Significant changes in the political conditions in markets in which we manufacture, sell or distribute our products, including quarantines, governmental or regulatory actions, closures or other restrictions that limit or close our operating and manufacturing facilities, restrict our employees’ ability to travel or perform necessary business functions, restrict or prevent consumers from having access to our products, or otherwise prevent our third-party

partners, suppliers, or customers from sufficiently staffing operations, including operations necessary for the production, distribution, sale, and support of our products, which could adversely impact our results.

These impacts have had and could continue to have a negative effect on our business, financial condition, results of operations and cash flows, as well as the trading price of our securities. In light of the adverse impact on our near-term revenues, earnings, liquidity and cash flows, we have taken and expect to continue to implement measures to reduce discretionary expenses and manage costs. See the discussion on our response to COVID-19 in Item 2 “Management’s Discussion and Analysis of Financial Condition and Results of Operations— Overview” and “—Liquidity and Capital Resources.” These measures may not achieve results in accordance with our expectations or on the timelines we anticipate. Despite our efforts to manage and remedy these impacts to the Company, their ultimate impact also depends on factors beyond our knowledge or control, including the duration and severity of the COVID-19 pandemic as well as third-party actions taken to contain its spread and mitigate its public health effects.

Filed May 11, 2020.
Source: SEC EDGAR, the filing index for accession 0001024305-20-000049. Last ingested by Listed: Nov 11, 2026, 03:30 ET. No prices; not investment advice.
